ACTG Publications

TitleAuthorsDateJournalIssueVolume
25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings.Havers, Fiona ; Smeaton, Laura ; Gupte, Nikhil ; Detrick, Barbara ; Bollinger, Robert C ; Hakim, James ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Christian, Parul ; Lama, Javier R ; Campbell, Thomas B ; Gupta, Amita ; ACTG PEARLS ; NWCS 319 Study Teams2014 Jul 15J Infect Dis2210
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Daar, Eric S ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Feinberg, Judith ; Tashima, Karen ; Murphy, Robert L ; Fischl, Margaret A ; AIDS Clinical 2011 Oct 15J Infect Dis8204
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Fischl, Margaret A ; Mollan, Katie ; Peeples, Lynne ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Koletar, Susan L ; Johnson, Victoria A ; Geiseler, P Jan ; Daar, Eric S ; AIDS Clinical 2009 Dec 3N Engl J Med23361
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.Valcour, V ; Yeh, T-M ; Bartt, R ; Clifford, D ; Gerschenson, M ; Evans, S R ; Cohen, B A ; Ebenezer, G J ; Hauer, P ; Millar, L ; Gould, M ; Tran, P ; Shikuma, C ; Souza, S ; McArthur, J C ; AIDS Clinical Trials Group (ACTG) 5157 protocol team2009 FebHIV Med210
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.Wheat, L Joseph ; Connolly, Patricia ; Smedema, Melinda ; Durkin, Michelle ; Brizendine, Edward ; Mann, Paul ; Patel, Reena ; McNicholas, Paul M ; Goldman, Mitchell2006 JunJ Antimicrob Chemother657
Adaptation to different human populations by HIV-1 revealed by codon-based analyses.Pond, Sergei L Kosakovsky ; Frost, Simon D W ; Grossman, Zehava ; Gravenor, Michael B ; Richman, Douglas D ; Brown, Andrew J Leigh2006 Jun 23PLoS Comput Biol62
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs.John, Mina ; Heckerman, David ; James, Ian ; Park, Lawrence P ; Carlson, Jonathan M ; Chopra, Abha ; Gaudieri, Silvana ; Nolan, David ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Mallal, Simon2010 Apr 15J Immunol8184
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Amorosa, Valerianna K ; Luetkemeyer, Anne ; Kang, Minhee ; Johnson, Victoria A ; Umbleja, Triin ; Haas, David W ; Yesmin, Suria ; Bardin, Matthew C ; Chung, Ray T ; Alston-Smith, Beverly ; Tebas, Pablo ; Peters, Marion G2013 Nov-DecHIV Clin Trials614
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.Canter, Jeffrey A ; Robbins, Gregory K ; Selph, Doug ; Clifford, David B ; Kallianpur, Asha R ; Shafer, Robert ; Levy, Shawn ; Murdock, Deborah G ; Ritchie, Marylyn D ; Haas, David W ; Hulgan, Todd ; AIDS Clinical Trials Group Study 384 Team ; New Work Concept Sheet 273 Team2010 Jun 1J Infect Dis11201
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Crawford, Keith W ; Spritzler, John ; Kalayjian, Robert C ; Parsons, Teresa ; Landay, Alan ; Pollard, Richard ; Stocker, Vicki ; Lederman, Michael M ; Flexner, Charles ; AIDS Clinical Trials Protocol 5015 Team2010 JunAIDS Res Hum Retroviruses626
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.Schooley, Robert T ; Spritzler, John ; Wang, Hongying ; Lederman, Michael M ; Havlir, Diane ; Kuritzkes, Daniel R ; Pollard, Richard ; Battaglia, Cathy ; Robertson, Michael ; Mehrotra, Devan ; Casimiro, Danilo ; Cox, Kara ; Schock, Barbara ; AIDS Clinical Trials Group 5197 Study Team2010 Sep 1J Infect Dis5202
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.Smurzynski, Marlene ; Collier, Ann C ; Koletar, Susan L ; Bosch, Ronald J ; Wu, Kunling ; Bastow, Barbara ; Benson, Constance A2008 Jul-AugHIV Clin Trials49
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.McComsey, Grace A ; Kendall, Michelle A ; Tebas, Pablo ; Swindells, Susan ; Hogg, Evelyn ; Alston-Smith, Beverly ; Suckow, Carol ; Gopalakrishnan, Geetha ; Benson, Constance ; Wohl, David A2007 Nov 30AIDS1821
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.Stüve, Olaf ; Marra, Christina M ; Bar-Or, Amit ; Niino, Masaaki ; Cravens, Petra D ; Cepok, Sabine ; Frohman, Elliot M ; Phillips, J Theodore ; Arendt, Gabriele ; Jerome, Keith R ; Cook, Linda ; Grand'Maison, Francois ; Hemmer, Bernhard ; Monson, Nancy L ; Racke, Michael K2006 OctArch Neurol1063
Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy.McCausland, Marie R ; Juchnowski, Steven M ; Zidar, David A ; Kuritzkes, Daniel R ; Andrade, Adriana ; Sieg, Scott F ; Lederman, Michael M ; Funderburg, Nicholas T2015PLoS One1010
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).Gripshover, Barbara M ; Ribaudo, Heather ; Santana, Jorge ; Gerber, John G ; Campbell, Thomas B ; Hogg, Evelyn ; Jarocki, Bernadette ; Hammer, Scott M ; Kuritzkes, Daniel R ; A5118 Team2006Antivir Ther511
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.Eshleman, Susan H ; Hudelson, Sarah E ; Redd, Andrew D ; Wang, Lei ; Debes, Rachel ; Chen, Ying Q ; Martens, Craig A ; Ricklefs, Stacy M ; Selig, Ethan J ; Porcella, Stephen F ; Munshaw, Supriya ; Ray, Stuart C ; Piwowar-Manning, Estelle ; McCauley, Marybeth ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Hakim, James G ; Chariyalertsak, Su2011 Dec 15J Infect Dis12204
Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.Atkinson, Benjamin E ; Krishnan, Supriya ; Cox, Gary ; Hulgan, Todd ; Collier, Ann C2013PLoS One68
Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.Rosenkranz, Susan L ; Yarasheski, Kevin E ; Para, Michael F ; Reichman, Richard C ; Morse, Gene D2007 JunMetab Syndr Relat Disord25
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.Taiwo, Babafemi ; Gallien, Sebastien ; Aga, Evgenia ; Ribaudo, Heather ; Haubrich, Richard ; Kuritzkes, Daniel R ; Eron, Joseph J2011 Aug 15J Infect Dis4204
Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.Naggie, Susanna ; Patel, Keyur ; Yang, Lan-Yan ; Chow, Shein-Chung ; Johnson, Victoria ; Guyton, John R ; Muir, Andrew J ; Sulkowski, Mark ; Hicks, Charles2015 AprOpen Forum Infect Dis22
Antiretroviral therapies in women after single-dose nevirapine exposure.Lockman, Shahin ; Hughes, Michael D ; McIntyre, James ; Zheng, Yu ; Chipato, Tsungai ; Conradie, Francesca ; Sawe, Fred ; Asmelash, Aida ; Hosseinipour, Mina C ; Mohapi, Lerato ; Stringer, Elizabeth ; Mngqibisa, Rosie ; Siika, Abraham ; Atwine, Diana ; Hakim, James ; Shaffer, Douglas ; Kanyama, Cecilia ; Wools-Kaloustian, Kara ; Salata, Ro2010 Oct 14N Engl J Med16363
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Benson, Constance A ; Hosseinipour, Mina C ; Campbell, Thomas B ; Gulick, Roy M ; Daar, Eric S ; Sax, Paul E ; Riddler, Sharon A ; Haubrich, Richard ; Salata, Robert A ; Currier, Judith S2014 Sep 15Clin Infect Dis659
Antiretroviral therapy for HIV-1-infected children in Haiti.George, Erik ; Noël, Francine ; Bois, Gyrlande ; Cassagnol, Rachelle ; Estavien, Louise ; Rouzier, Patricia De Matteis ; Verdier, Rose I ; Johnson, Warren D ; Pape, Jean W ; Fitzgerald, Daniel W ; Wright, Peter F2007 May 15J Infect Dis10195
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.Volberding, Paul ; Demeter, Lisa ; Bosch, Ronald J ; Aga, Evgenia ; Pettinelli, Carla ; Hirsch, Martin ; Vogler, Mary ; Martinez, Ana ; Little, Susan ; Connick, Elizabeth ; ACTG 371 Team2009 Sep 24AIDS1523
Antiviral drug resistance.Richman, Douglas D2006 SepAntiviral Res2-371
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.Hosoya, Noriaki ; Su, Zhaohui ; Wilkin, Timothy ; Gulick, Roy M ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Giguel, Francoise ; Greaves, Wayne L ; Coakley, Eoin ; Kuritzkes, Daniel R2009 AugJ Clin Microbiol847
Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.Yiannoutsos, Constantin T ; Nakas, Christos T ; Navia, Bradford A ; proton MRS Consortium2008 Mar 1Neuroimage140
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.Mollan, Katie R ; Smurzynski, Marlene ; Eron, Joseph J ; Daar, Eric S ; Campbell, Thomas B ; Sax, Paul E ; Gulick, Roy M ; Na, Lumine ; O'Keefe, Lauren ; Robertson, Kevin R ; Tierney, Camlin2014 Jul 1Ann Intern Med1161
Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months.Cu-Uvin, Susan ; Snyder, Brad ; Harwell, Joseph I ; Hogan, Joseph ; Chibwesha, Carla ; Hanley, Dawn ; Ingersoll, Jessica ; Kurpewski, Jaclynn ; Mayer, Kenneth H ; Caliendo, Angela M2006 Aug 15J Acquir Immune Defic Syndr542
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.Brown, Todd T ; Tassiopoulos, Katherine ; Bosch, Ronald J ; Shikuma, Cecilia ; McComsey, Grace A2010 OctDiabetes Care1033
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.Demeter, Lisa M ; Degruttola, Victor ; Lustgarten, Stephanie ; Bettendorf, Daniel ; Fischl, Margaret ; Eshleman, Susan ; Spreen, William ; Nguyen, Bach-Yen ; Koval, Christine E ; Eron, Joseph J ; Hammer, Scott ; Squires, Kathleen2008 Jan-FebHIV Clin Trials19
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).McLinden, Robert J ; Paris, Robert M ; Polonis, Victoria R ; Close, Nicole C ; Su, Zhaohui ; Shikuma, Cecilia M ; Margolis, David M ; Kim, Jerome H2012 Jan 2AIDS126
Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy.Kang, M ; Cu-Uvin, S2012 JulHIV Med613
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.Cohn, Susan E ; Jiang, Hongyu ; McCutchan, J Allen ; Koletar, Susan L ; Murphy, Robert L ; Robertson, Kevin R ; de St Maurice, Annabelle M ; Currier, Judith S ; Williams, Paige L2011 JunAIDS Care623
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.McLaren, Paul J ; Coulonges, Cédric ; Ripke, Stephan ; van den Berg, Leonard ; Buchbinder, Susan ; Carrington, Mary ; Cossarizza, Andrea ; Dalmau, Judith ; Deeks, Steven G ; Delaneau, Olivier ; De Luca, Andrea ; Goedert, James J ; Haas, David ; Herbeck, Joshua T ; Kathiresan, Sekar ; Kirk, Gregory D ; Lambotte, Olivier ; Luo, Ma ; Mallal, 2013PLoS Pathog79
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.Foulkes, Andrea S ; Wohl, David A ; Frank, Ian ; Puleo, Elaine ; Restine, Stephanie ; Wolfe, Megan L ; Dubé, Michael P ; Tebas, Pablo ; Reilly, Muredach P2006 MarPLoS Med33
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Daar, Eric S2014 Feb 1J Acquir Immune Defic Syndr265
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy.Taiwo, Babafemi ; Matining, Roy M ; Zheng, Lu ; Lederman, Michael M ; Rinaldo, Charles R ; Kim, Peter S ; Berzins, Baiba I ; Kuritzkes, Daniel R ; Jennings, Amy ; Eron, Joseph J ; Wilson, Cara C2013 AugJ Antimicrob Chemother868
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.Daar, Eric S ; Tierney, Camlin ; Fischl, Margaret A ; Sax, Paul E ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Pappa, Keith A ; Woodward, William C ; Patterson, Kristine ; Bolivar, Hector ; Benson, Constance A ; Collier, Ann C ; AIDS2011 Apr 5Ann Intern Med7154
Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection.Connick, Elizabeth ; Bosch, Ronald J ; Aga, Evgenia ; Schlichtemeier, Rick ; Demeter, Lisa M ; Volberding, Paul ; ACTG 709 Team2011 Sep 1J Acquir Immune Defic Syndr158
Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution.Reynolds, N R ; Neidig, J L ; Wu, A W ; Gifford, A L ; Holmes, W C2006 OctAIDS Care718
Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants.Saberi, Parya ; Neilands, Torsten B ; Vittinghoff, Eric ; Johnson, Mallory O ; Chesney, Margaret ; Cohn, Susan E2015 MarAIDS Patient Care STDS329
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals.Hoffman, Risa M ; Jamieson, Beth D ; Bosch, Ronald J ; Currier, Judith ; Kitchen, Christina M R ; Schmid, Ingrid ; Zhu, Yuda ; Bennett, Kara ; Mitsuyasu, Ronald2011 OctJ Clin Immunol531
Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection.Anthony, Donald D ; Conry, Sara J ; Medvik, Kathy ; Sandhya Rani, M R ; Falck-Ytter, Yngve ; Blanton, Ronald E ; Lederman, Michael M ; Rodriguez, Benigno ; Landay, Alan L ; Sandberg, Johan K2012 Sep 15J Infect Dis6206
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).McKinnon, John E ; Mailliard, Robbie B ; Swindells, Susan ; Wilkin, Timothy J ; Borowski, Luann ; Roper, Jillian M ; Bastow, Barbara ; Kearney, Mary ; Wiegand, Ann ; Mellors, John W ; Rinaldo, Charles R ; A5201 study team2014PLoS One59
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.De Boni, Raquel B ; Zheng, Lu ; Rosenkranz, Susan L ; Sun, Xin ; Lavenberg, Jeffrey ; Cardoso, Sandra W ; Grinsztejn, Beatriz ; La Rosa, Alberto ; Pierre, Samuel ; Severe, Patrice ; Cohn, Susan E ; Collier, Ann C ; Gross, Robert2016 Feb 1Drug Alcohol Depend159
Biology of CCR5 and its role in HIV infection and treatment.Lederman, Michael M ; Penn-Nicholson, Adam ; Cho, Michael ; Mosier, Donald2006 Aug 16JAMA7296
Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.Kelesidis, Theodoros ; Kendall, Michelle A ; Yang, Otto O ; Hodis, Howard N ; Currier, Judith S2012 Nov 15J Infect Dis10206
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.Halvas, Elias K ; Aldrovandi, Grace M ; Balfe, Peter ; Beck, Ingrid A ; Boltz, Valerie F ; Coffin, John M ; Frenkel, Lisa M ; Hazelwood, J Darren ; Johnson, Victoria A ; Kearney, Mary ; Kovacs, Andrea ; Kuritzkes, Daniel R ; Metzner, Karin J ; Nissley, Dwight V ; Nowicki, Marek ; Palmer, Sarah ; Ziermann, Rainer ; Zhao, Richard Y ; Jenning2006 JulJ Clin Microbiol744
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Sax, Paul E ; Komarow, Lauren ; Finkelman, Malcolm A ; Grant, Philip M ; Andersen, Janet ; Scully, Eileen ; Powderly, William G ; Zolopa, Andrew R ; AIDS Clinical Trials Group Study A5164 Team2011 Jul 15Clin Infect Dis253
Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.McComsey, Grace A ; Moser, Carlee ; Currier, Judith ; Ribaudo, Heather J ; Paczuski, Pawel ; Dubé, Michael P ; Kelesidis, Theodoros ; Rothenberg, Jennifer ; Stein, James H ; Brown, Todd T2016 Apr 1Clin Infect Dis762
Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals.Brown, Todd T ; Chen, Yun ; Currier, Judith S ; Ribaudo, Heather J ; Rothenberg, Jennifer ; Dubé, Michael P ; Murphy, Robert ; Stein, James H ; McComsey, Grace A2013 Jul 1J Acquir Immune Defic Syndr363
Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy.Palermo, Brandon ; Bosch, Ronald J ; Bennett, Kara ; Jacobson, Jeffrey M2011 Jul-AugHIV Clin Trials412
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTGMcComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Tebas, Pablo ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Sax, Paul E2011 Jun 15J Infect Dis12203
Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142.Huang, Jeannie S ; Hughes, Michael D ; Riddler, Sharon A ; Haubrich, Richard H ; Aids Clinical Trials Group A5142 Study Team2013 Sep-OctHIV Clin Trials514
Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.Treasure, Graham C ; Aga, Evgenia ; Bosch, Ronald J ; Mellors, John W ; Kuritzkes, Daniel R ; Para, Michael ; Gandhi, Rajesh T ; Li, Jonathan Z2016 Jul 1J Acquir Immune Defic Syndr372
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.Dumond, Julie B ; Rigdon, Joseph ; Mollan, Katie ; Tierney, Camlin ; Kashuba, Angela D M ; Aweeka, Francesca ; Collier, Ann C2015 Dec 15J Acquir Immune Defic Syndr570
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).Shaffer, Douglas ; Hughes, Michael D ; Sawe, Fredrick ; Bao, Yajing ; Moses, Agnes ; Hogg, Evelyn ; Lockman, Shahin ; Currier, Judith2014 Jun 1J Acquir Immune Defic Syndr266
CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.Henrich, Timothy J ; Hanhauser, Emily ; Harrison, Linda J ; Palmer, Christine D ; Romero-Tejeda, Marisol ; Jost, Stephanie ; Bosch, Ronald J ; Kuritzkes, Daniel R2016 Mar 1J Infect Dis5213
CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.Judge, Chelsey J ; Sandberg, Johan K ; Funderburg, Nicholas T ; Sherman, Ken E ; Butt, Adeel A ; Kang, Minhee ; Landay, Alan L ; Lederman, Michael M ; Anthony, Donald D2016 Jun 1J Acquir Immune Defic Syndr
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.Tassiopoulos, Katherine ; Landay, Alan ; Collier, Ann C ; Connick, Elizabeth ; Deeks, Steven G ; Hunt, Peter ; Lewis, Dorothy E ; Wilson, Cara ; Bosch, Ronald2012 JunJ Infect Dis11205
CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.Vahey, Maryanne T ; Wang, Zhining ; Su, Zhaohui ; Nau, Martin E ; Krambrink, Amy ; Skiest, Daniel J ; Margolis, David M2008 AugAIDS Res Hum Retroviruses824
CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy.Taiwo, Babafemi ; Hunt, Peter W ; Gandhi, Rajesh T ; Ellingson, Andrew ; McKenna, Matthew ; Jacobson, Jeffrey M ; Gripshover, Barbara ; Bosch, Ronald J2013 May 1J Acquir Immune Defic Syndr163
Challenges in using observational studies to evaluate adverse effects of treatment.Hughes, Michael D ; Williams, Paige L2007 Apr 26N Engl J Med17356
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.Shikuma, Cecilia M ; Ribaudo, Heather J ; Zheng, Yu ; Gulick, Roy M ; Meyer, William A ; Tashima, Karen T ; Bastow, Barbara ; Kuritzkes, Daniel R ; Glesby, Marshall J ; AIDS Clinical Trials Group A5095 Study Team2011 MayAIDS Res Hum Retroviruses527
Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings.Havers, Fiona P ; Detrick, Barbara ; Cardoso, Sandra W ; Berendes, Sima ; Lama, Javier R ; Sugandhavesa, Patcharaphan ; Mwelase, Noluthando H ; Campbell, Thomas B ; Gupta, Amita ; ACTG A5175 PEARLS and NWCS319 Study Teams2014PLoS One49
Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir.Brown, Todd T ; Moser, Carlee ; Currier, Judith S ; Ribaudo, Heather J ; Rothenberg, Jennifer ; Kelesidis, Theodoros ; Yang, Otto ; Dubé, Michael P ; Murphy, Robert L ; Stein, James H ; McComsey, Grace A2015 Oct 15J Infect Dis8212
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.McComsey, Grace A ; Daar, Eric S ; O'Riordan, MaryAnn ; Collier, Ann C ; Kosmiski, Lisa ; Santana, Jorge L ; Fichtenbaum, Carl J ; Fink, Heidi ; Sax, Paul E ; Libutti, Daniel E ; Gerschenson, Mariana2013 Feb 15J Infect Dis4207
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.Fiscus, Susan A ; Cu-Uvin, Susan ; Eshete, Abel Tilahun ; Hughes, Michael D ; Bao, Yajing ; Hosseinipour, Mina ; Grinsztejn, Beatriz ; Badal-Faesen, Sharlaa ; Dragavon, Joan ; Coombs, Robert W ; Braun, Ken ; Moran, Laura ; Hakim, James ; Flanigan, Timothy ; Kumarasamy, N ; Campbell, Thomas B ; A5185s Team2013 JulClin Infect Dis257
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Kelesidis, Theodoros ; Tran, Thuy Tien T ; Stein, James H ; Brown, Todd T ; Moser, Carlee ; Ribaudo, Heather J ; Dubé, Michael P ; Murphy, Robert ; Yang, Otto O ; Currier, Judith S ; McComsey, Grace A2015 Aug 15Clin Infect Dis461
Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.Dirajlal-Fargo, Sahera ; Moser, Carlee ; Brown, Todd T ; Kelesidis, Theodoros ; Dubé, Michael P ; Stein, James H ; Currier, Judith ; McComsey, Grace A2016 SepOpen Forum Infect Dis33
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.Kelesidis, Theodoros ; Moser, Carlee ; Stein, James H ; Brown, Todd T ; Tran, Thuy Tien T ; Ribaudo, Heather J ; Dubé, Michael P ; Yang, Otto O ; Currier, Judith S ; McComsey, Grace A2016 Jun 28J Infect Dis
Changes in metabolic syndrome status after initiation of antiretroviral therapy.Krishnan, Supriya ; Schouten, Jeffrey T ; Atkinson, Benjamin ; Brown, Todd T ; Wohl, David A ; McComsey, Grace A ; Glesby, Marshall J ; Shikuma, Cecilia ; Haubrich, Richard ; Jacobson, Denise L2015 Jan 1J Acquir Immune Defic Syndr168
Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s.Kelesidis, Theodoros ; Tran, Thuy Tien T ; Brown, Todd T ; Moser, Carlee ; Ribaudo, Heather J ; Dubé, Michael P ; Yang, Otto O ; McComsey, Grace A ; Stein, James H ; Currier, Judith S2016 Sep 23Antivir Ther
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Wyatt, Christina M ; Kitch, Douglas ; Gupta, Samir K ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Ha, Belinda ; Melbourne, Kathleen ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 Sep 1J Acquir Immune Defic Syndr167
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment.Bosch, Ronald J ; Wang, Rui ; Vaida, Florin ; Lederman, Michael M ; Albrecht, Mary A2006 Dec 1J Acquir Immune Defic Syndr443
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.Li, Jonathan Z ; Brumme, Chanson J ; Lederman, Michael M ; Brumme, Zabrina L ; Wang, Hongying ; Spritzler, John ; Carrington, Mary ; Medvik, Kathleen ; Walker, Bruce D ; Schooley, Robert T ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012PLoS One37
Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.Robbins, Gregory K ; Cohn, Susan E ; Harrison, Linda J ; Smeaton, Laura ; Moran, Laura ; Rusin, David ; Dehlinger, Marjorie ; Flynn, Theresa ; Lammert, Sara ; Wu, Albert W ; Safren, Steven A ; Reynolds, Nancy R2016 JulHIV Clin Trials417
Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partners.Smith, Davey M ; Drumright, Lydia N ; Frost, Simon D W ; Cheng, W Susan ; Espitia, Stephen ; Daar, Eric S ; Little, Susan J ; Gorbach, Pamina M2006 Dec 15J Acquir Immune Defic Syndr543
Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort.Thio, Chloe L ; Smeaton, Laura ; Saulynas, Melissa ; Hwang, Hyon ; Saravanan, Shanmugam ; Saravan, Shanmugam ; Kulkarni, Smita ; Hakim, James ; Nyirenda, Mulinda ; Iqbal, Hussain S ; Lalloo, Umesh G ; Mehta, Anand S ; Hollabaugh, Kimberly ; Campbell, Thomas B ; Lockman, Shahin ; Currier, Judith S2013 Jan 14AIDS227
Childhood abuse and initial presentation for HIV care: an opportunity for early intervention.Mugavero, M J ; Pence, B W ; Whetten, K ; Leserman, J ; Swartz, M ; Stangl, D ; Thielman, N M2007 OctAIDS Care919
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.De Luca, Andrea ; Ammassari, Adriana ; Pezzotti, Patrizio ; Cinque, Paola ; Gasnault, Jacques ; Berenguer, Juan ; Di Giambenedetto, Simona ; Cingolani, Antonella ; Taoufik, Yassine ; Miralles, Pilar ; Marra, Christina M ; Antinori, Andrea ; Gesida 9/99, IRINA, ACTG 363 Study Groups2008 Sep 12AIDS1422
Class-sparing regimens for initial treatment of HIV-1 infection.Riddler, Sharon A ; Haubrich, Richard ; DiRienzo, A Gregory ; Peeples, Lynne ; Powderly, William G ; Klingman, Karin L ; Garren, Kevin W ; George, Tania ; Rooney, James F ; Brizz, Barbara ; Lalloo, Umesh G ; Murphy, Robert L ; Swindells, Susan ; Havlir, Diane ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Team2008 May 15N Engl J Med20358
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.Vardhanabhuti, Saran ; Acosta, Edward P ; Ribaudo, Heather J ; Severe, Patrice ; Lalloo, Umesh ; Kumarasamy, Nagalingeshwaran ; Taulo, Frank ; Kabanda, Joseph ; Oneko, Olola ; Ive, Prudence ; Sambarey, Pradeep ; Chan, Ellen S ; Hitti, Jane ; Hong, Francis ; McMahon, Deborah ; Haas, David W ; A5207 ACTG Study Team2013 Aug 15J Infect Dis4208
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Sanchez, Alejandro ; Sattler, Fred R ; Asmuth, David M ; Pollard, Richard B ; Zolopa, Andrew R2014 Jul-AugHIV Clin Trials415
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.Wohl, David A ; Kendall, Michelle A ; Feinberg, Judith ; Alston-Smith, Beverly ; Owens, Susan ; Chafey, Suzette ; Marco, Michael ; Maxwell, Sharon ; Benson, Constance ; Keiser, Philip ; van der Horst, Charles ; Jacobson, Mark A ; A5030 Study Team2013PLoS One118
Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.Schifitto, Giovanni ; Deng, Lijuan ; Yeh, Tzu-min ; Evans, Scott R ; Ernst, Thomas ; Zhong, Jianhui ; Clifford, David2011 FebJ Neurovirol117
Clinical perspectives on human genetic screening to prevent nevirapine toxicity.Haas, David W ; Mootsikapun, Piroon ; Ruxrungtham, Kiat ; Podzamczer, Daniel ; Nevirapine Toxicogenomics Study Team2012 Sep 1Per Med79
Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.Smith, Davey ; Moini, Niousha ; Pesano, Rick ; Cachay, Edward ; Aiem, Heidi ; Lie, Yolanda ; Richman, Douglas ; Little, Susan2007 Feb 1Clin Infect Dis344
A closer look at depression and its relationship to HIV antiretroviral adherence.Wagner, Glenn J ; Goggin, Kathy ; Remien, Robert H ; Rosen, Marc I ; Simoni, Jane ; Bangsberg, David R ; Liu, Honghu ; MACH14 Investigators2011 DecAnn Behav Med342
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).Gange, Stephen J ; Kitahata, Mari M ; Saag, Michael S ; Bangsberg, David R ; Bosch, Ronald J ; Brooks, John T ; Calzavara, Liviana ; Deeks, Steven G ; Eron, Joseph J ; Gebo, Kelly A ; Gill, M John ; Haas, David W ; Hogg, Robert S ; Horberg, Michael A ; Jacobson, Lisa P ; Justice, Amy C ; Kirk, Gregory D ; Klein, Marina B ; Martin, Jeffrey 2007 AprInt J Epidemiol236
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.Vogler, Mary A ; Smeaton, Laura M ; Wright, Rodney L ; Cardoso, Sandra W ; Sanchez, Jorge ; Infante, Rosa ; Moran, Laura E ; Godfrey, Catherine ; Demeter, Lisa M ; Johnson, Victoria A2014 Apr 15J Acquir Immune Defic Syndr565
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.Luetkemeyer, Anne F ; Rosenkranz, Susan L ; Lu, Darlene ; Grinsztejn, Beatriz ; Sanchez, Jorge ; Ssemmanda, Michael ; Sanne, Ian ; McIlleron, Helen ; Havlir, Diane V ; Haas, David W ; Adult AIDS Clinical Trials Group A5221 and A5243 Study Teams2015 Jun 15Clin Infect Dis1260
Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations.Healy, Brian ; De Gruttola, Victor ; Pagano, Marcello2007 SepBiometrics363
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.Mugavero, Michael J ; May, Margaret ; Ribaudo, Heather J ; Gulick, Roy M ; Riddler, Sharon A ; Haubrich, Richard ; Napravnik, Sonia ; Abgrall, Sophie ; Phillips, Andrew ; Harris, Ross ; Gill, M John ; de Wolf, Frank ; Hogg, Robert ; Günthard, Huldrych F ; Chêne, Geneviève ; D'Arminio Monforte, Antonella ; Guest, Jodie L ; Smith, Colette ; 2011 Nov 1J Acquir Immune Defic Syndr358
Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview.Bartlett, John A ; Chen, Shan-Shan ; Quinn, Joseph B2007 Jul-AugHIV Clin Trials48
Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087.Evans, Scott R ; Fichtenbaum, Carl J ; Aberg, Judith A ; A5087 Study Team2007 Jan-FebHIV Clin Trials18
Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.Thio, Chloe L ; Smeaton, Laura ; Hollabaugh, Kimberly ; Saulynas, Melissa ; Hwang, Hyon ; Saravanan, Shanmugam ; Kulkarni, Smita ; Hakim, James ; Nyirenda, Mulinda ; Iqbal, Hussain Syed ; Lalloo, Umesh G ; Campbell, Thomas B ; Lockman, Shahin ; Currier, Judith S2015 Jun 19AIDS1029
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy.Li, Jonathan Z ; Chapman, Brad ; Charlebois, Patrick ; Hofmann, Oliver ; Weiner, Brian ; Porter, Alyssa J ; Samuel, Reshmi ; Vardhanabhuti, Saran ; Zheng, Lu ; Eron, Joseph ; Taiwo, Babafemi ; Zody, Michael C ; Henn, Matthew R ; Kuritzkes, Daniel R ; Hide, Winston ; ACTG A5262 Study Team ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward2014PLoS One39
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.Macatangay, Bernard J C ; Zheng, Lu ; Rinaldo, Charles R ; Landay, Alan L ; Pollard, Richard B ; Pahwa, Savita ; Lederman, Michael M ; Bucy, R Pat2010 SepClin Vaccine Immunol917
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.Flexner, Charles ; Tierney, Camlin ; Gross, Robert ; Andrade, Adriana ; Lalama, Christina ; Eshleman, Susan H ; Aberg, Judith ; Sanne, Ian ; Parsons, Teresa ; Kashuba, Angela ; Rosenkranz, Susan L ; Kmack, Anne ; Ferguson, Elaine ; Dehlinger, Marjorie ; Mildvan, Donna ; ACTG A5073 Study Team2010 Apr 1Clin Infect Dis750
A comparison of tests for restricted orderings in the three-class case.Alonzo, Todd A ; Nakas, Christos T ; Yiannoutsos, Constantin T ; Bucher, Sherri2009 Mar 30Stat Med728
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.Ofotokun, Ighovwerha ; Na, Lumine H ; Landovitz, Raphael J ; Ribaudo, Heather J ; McComsey, Grace A ; Godfrey, Catherine ; Aweeka, Francesca ; Cohn, Susan E ; Sagar, Manish ; Kuritzkes, Daniel R ; Brown, Todd T ; Patterson, Kristine B ; Para, Michael F ; Leavitt, Randi Y ; Villasis-Keever, Angelina ; Baugh, Bryan P ; Lennox, Jeffrey L ; Cu2015 Jun 15Clin Infect Dis1260
Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.Lalama, Christina M ; Jennings, Cheryl ; Johnson, Victoria A ; Coombs, Robert W ; McKinnon, John E ; Bremer, James W ; Cobb, Bryan R ; Cloherty, Gavin A ; Mellors, John W ; Ribaudo, Heather J ; AIDS Clinical Trials Group2015 AugJ Clin Microbiol853
A comparison of three initial antiretroviral AIDS regimens.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Sep 6N Engl J Med10357
Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.Firnhaber, Cynthia ; Smeaton, Laura ; Saukila, Nasinuku ; Flanigan, Timothy ; Gangakhedkar, Raman ; Kumwenda, Johnstone ; La Rosa, Alberto ; Kumarasamy, Nagalingeswaran ; De Gruttola, Victor ; Hakim, James Gita ; Campbell, Thomas B2010 DecInt J Infect Dis1214
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.Okusanya, Olanrewaju ; Forrest, Alan ; DiFrancesco, Robin ; Bilic, Sanela ; Rosenkranz, Susan ; Para, Michael F ; Adams, Elizabeth ; Yarasheski, Kevin E ; Reichman, Richard C ; Morse, Gene D ; ACTG 5043 Protocol Team2007 MayAntimicrob Agents Chemother551
A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay.Day, John R ; Martínez, Laura E ; Sásik, Roman ; Hitchin, Douglas L ; Dueck, Megan E ; Richman, Douglas D ; Guatelli, John C2006 OctJ Virol Methods1137
Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.Shivakoti, Rupak ; Yang, Wei-Teng ; Gupte, Nikhil ; Berendes, Sima ; Rosa, Alberto La ; Cardoso, Sandra W ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Riviere, Cynthia ; Sugandhavesa, Patcharaphan ; Santos, Brento ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Bollinger, Robert C ; Currier, Judith S ; Ta2015 Jul 1Clin Infect Dis161
Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort.Balagopal, Ashwin ; Gupte, Nikhil ; Shivakoti, Rupak ; Cox, Andrea L ; Yang, Wei-Teng ; Berendes, Sima ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Semba, Rich2016 SepOpen Forum Infect Dis33
Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.Riddler, Sharon A ; Aga, Evgenia ; Bosch, Ronald J ; Bastow, Barbara ; Bedison, Margaret ; Vagratian, David ; Vaida, Florin ; Eron, Joseph J ; Gandhi, Rajesh T ; Mellors, John W ; ACTG A5276s Protocol Team2016 Feb 15J Infect Dis4213
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).Bosch, Ronald J ; Pollard, Richard B ; Landay, Alan ; Aga, Evgenia ; Fox, Lawrence ; Mitsuyasu, Ronald2010AIDS Res Ther7
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.Vogler, Mary A ; Patterson, Kristine ; Kamemoto, Lori ; Park, Jeong-Gun ; Watts, Heather ; Aweeka, Francesca ; Klingman, Karin L ; Cohn, Susan E2010 DecJ Acquir Immune Defic Syndr455
Controlling healthcare-associated infections in the international research setting.Godfrey, Catherine ; Villa, Christie ; Dawson, Liza ; Swindells, Susan ; Schouten, Jeffrey T2013 Apr 1J Acquir Immune Defic Syndr462
Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.Melvin, Ann J ; Kang, Minhee ; Hitti, Jane ; Livingston, Elizabeth ; Cohn, Susan E ; Stocker, Vicki ; Ross, Allison C ; Watts, Heather ; McComsey, Grace A2008Antivir Ther313
Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy.Zhou, L ; Kitch, D W ; Evans, S R ; Hauer, P ; Raman, S ; Ebenezer, G J ; Gerschenson, M ; Marra, C M ; Valcour, V ; Diaz-Arrastia, R ; Goodkin, K ; Millar, L ; Shriver, S ; Asmuth, D M ; Clifford, D B ; Simpson, D M ; McArthur, J C ; NARC and ACTG A5117 Study Group2007 Jun 12Neurology2468
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.Carlson, Jonathan M ; Brumme, Chanson J ; Martin, Eric ; Listgarten, Jennifer ; Brockman, Mark A ; Le, Anh Q ; Chui, Celia K S ; Cotton, Laura A ; Knapp, David J H F ; Riddler, Sharon A ; Haubrich, Richard ; Nelson, George ; Pfeifer, Nico ; Deziel, Charles E ; Heckerman, David ; Apps, Richard ; Carrington, Mary ; Mallal, Simon ; Harrigan, 2012 DecJ Virol2486
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Girouard, Michael P ; Sax, Paul E ; Parker, Robert A ; Taiwo, Babafemi ; Freedberg, Kenneth A ; Gulick, Roy M ; Weinstein, Milton C ; Paltiel, A David ; Walensky, Rochelle P2016 Mar 15Clin Infect Dis662
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.Morris, Bethany L ; Scott, Callie A ; Wilkin, Timothy J ; Sax, Paul E ; Gulick, Roy M ; Freedberg, Kenneth A ; Schackman, Bruce R2012 Jan-FebHIV Clin Trials113
Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Schackman, Bruce R ; Haas, David W ; Park, Sanghee S ; Li, X Cynthia ; Freedberg, Kenneth A2015 DecPharmacogenomics1816
C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings.Tenforde, Mark W ; Gupte, Nikhil ; Dowdy, David W ; Asmuth, David M ; Balagopal, Ashwin ; Pollard, Richard B ; Sugandhavesa, Patcharaphan ; Lama, Javier R ; Pillay, Sandy ; Cardoso, Sandra W ; Pawar, Jyoti ; Santos, Breno ; Riviere, Cynthia ; Mwelase, Noluthando ; Kanyama, Cecilia ; Kumwenda, Johnstone ; Hakim, James G ; Kumarasamy, Nagali2015PLoS One210
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.Lederman, Michael M ; Smeaton, Laura ; Smith, Kim Y ; Rodriguez, Benigno ; Pu, Minya ; Wang, Hongying ; Sevin, Anne ; Tebas, Pablo ; Sieg, Scott F ; Medvik, Kathy ; Margolis, David M ; Pollard, Richard ; Ertl, Hildegund C J ; Valdez, Hernan2006 Dec 15J Infect Dis12194
Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.Gupta, Samir K ; Kitch, Douglas ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Melbourne, Kathleen ; Ha, Belinda ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 MarOpen Forum Infect Dis11
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.Weinberg, Adriana ; Tierney, Camlin ; Kendall, Michelle A ; Bosch, Ronald J ; Patterson-Bartlett, Julie ; Erice, Alejo ; Hirsch, Martin S ; Polsky, Bruce ; AIDS Clinical Trials Group 360 Team2006 Feb 15J Infect Dis4193
Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115.Tenorio, Allan R ; Jiang, Hongyu ; Zheng, Yu ; Bastow, Barbara ; Kuritzkes, Daniel R ; Bartlett, John A ; Deeks, Steven G ; Landay, Alan L ; Riddler, Sharon A2009 FebAIDS Res Hum Retroviruses225
Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.Cohn, S E ; Park, J-G ; Watts, D H ; Stek, A ; Hitti, J ; Clax, P A ; Yu, S ; Lertora, J J L ; ACTG A5093 Protocol Team2007 FebClin Pharmacol Ther281
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of theLuque, Amneris E ; Cohn, Susan E ; Park, Jeong-Gun ; Cramer, Yoninah ; Weinberg, Adriana ; Livingston, Elizabeth ; Klingman, Karin L ; Aweeka, Francesca ; Watts, D Heather2015 AprAntimicrob Agents Chemother459
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.Demeter, Lisa M ; Mukherjee, A Lisa ; DiFrancesco, Robin ; Jiang, Hongyu ; DiCenzo, Robert ; Bastow, Barbara ; Rinehart, Alex R ; Morse, Gene D ; Albrecht, Mary2008 Jan-FebHIV Clin Trials19
Design issues in initial HIV-treatment trials: focus on ACTG A5095.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Schackman, Bruce R ; Acosta, Edward P ; Shikuma, Cecilia M ; Gulick, Roy M2006Antivir Ther611
The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients.Zheng, Lu ; Rosenkranz, Susan L ; Taiwo, Babafemi ; Para, Michael F ; Eron, Joseph J ; Hughes, Michael D2013 AprAIDS Res Hum Retroviruses429
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.Seaman, William T ; Andrews, Elizabeth ; Couch, Marion ; Kojic, Erna M ; Cu-Uvin, Susan ; Palefsky, Joel ; Deal, Allison M ; Webster-Cyriaque, Jennifer2010Virol J7
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.Hare, C Bradley ; Mellors, John ; Krambrink, Amy ; Su, Zhaohui ; Skiest, Daniel ; Margolis, David M ; Patel, Sheran S ; Barnas, Douglas ; Frenkel, Lisa ; Coombs, Robert W ; Aweeka, Francesca ; Morse, Gene D ; Haas, David W ; Boltz, Valerie ; Palmer, Sarah ; Coffin, John ; Havlir, Diane V2008 Aug 1Clin Infect Dis347
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.Goicoechea, Miguel ; Smith, Davey M ; Liu, Lin ; May, Susanne ; Tenorio, Allan R ; Ignacio, Caroline C ; Landay, Alan ; Haubrich, Richard2006 Jul 1J Infect Dis1194
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.Firnhaber, Cynthia ; Smeaton, Laura M ; Grinsztejn, Beatriz ; Lalloo, Umesh ; Faesen, Sharla ; Samaneka, Wadzanai ; Infante, Rosa ; Rana, Aadia ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Campbell, Thomas B2015 May-JunHIV Clin Trials316
Differential CD4+ cell count increase and CD4+ :  CD8+ ratio normalization with maraviroc compared with tenofovir.Chan, Ellen S ; Landay, Alan L ; Brown, Todd T ; Ribaudo, Heather J ; Mirmonsef, Paria ; Ofotokun, Igho ; Weitzmann, M Neale ; Martinson, Jeffrey ; Klingman, Karin L ; Eron, Joseph J ; Fichtenbaum, Carl J ; Plants, Jill ; Taiwo, Babafemi O2016 Aug 24AIDS1330
Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Tierney, Camlin ; Ha, Belinda ; Brown, Todd T2015 Mar-AprHIV Clin Trials216
Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo.Katsounas, Antonios ; Frank, Astrid C ; Lempicki, Richard A ; Polis, Michael A ; Asmuth, David M ; Kottilil, Shyam2015J AIDS Clin Res16
Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.Henrich, Timothy J ; Lewine, Nicolas R P ; Lee, Sun-Hee ; Rao, Suhas S P ; Berro, Reem ; Gulick, Roy M ; Moore, John P ; Tsibris, Athe M N ; Kuritzkes, Daniel R2012 AprAntimicrob Agents Chemother456
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.Snoeck, Joke ; Kantor, Rami ; Shafer, Robert W ; Van Laethem, Kristel ; Deforche, Koen ; Carvalho, Ana Patricia ; Wynhoven, Brian ; Soares, Marcelo A ; Cane, Patricia ; Clarke, John ; Pillay, Candice ; Sirivichayakul, Sunee ; Ariyoshi, Koya ; Holguin, Africa ; Rudich, Hagit ; Rodrigues, Rosangela ; Bouzas, Maria Belen ; Brun-Vézinet, Franç2006 FebAntimicrob Agents Chemother250
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.Zhang, Xinyan ; Tierney, Camlin ; Albrecht, Mary ; Demeter, Lisa M ; Morse, Gene ; DiFrancesco, Robin ; Dykes, Carrie ; Jiang, Hongyu ; Haas, David W2013 AprTher Drug Monit235
Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study.Sun, Junfeng ; Nagaraj, H N ; Reynolds, Nancy R2007 AugBiom J549
Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis.Rouabhia, Mahmoud ; Semlali, Abdelhabib ; Chandra, Jyotsna ; Mukherjee, Pranab ; Chmielewski, Witold ; Ghannoum, Mahmoud A2012Mediators Inflamm2012
Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.Bednar, Maria M ; Hauser, Blake M ; Zhou, Shuntai ; Jacobson, Jeffrey M ; Eron, Joseph J ; Frank, Ian ; Swanstrom, Ronald2016 Aug 01J Infect Dis3214
Double robust and efficient estimation of a prognostic model for events in the presence of dependent censoring.Schnitzer, Mireille E ; Lok, Judith J ; Bosch, Ronald J2016 JanBiostatistics117
Drug susceptibility and resistance mutations after first-line failure in resource limited settings.Wallis, Carole L ; Aga, Evgenia ; Ribaudo, Heather ; Saravanan, Shanmugam ; Norton, Michael ; Stevens, Wendy ; Kumarasamy, Nagalingeswaran ; Bartlett, John ; Katzenstein, David ; A5230 team2014 Sep 1Clin Infect Dis559
Drug-resistant virus has reduced ability to induce immune activation.Wang, Rui ; Bosch, Ronald J ; Benson, Constance A ; Lederman, Michael M2012 Dec 1J Acquir Immune Defic Syndr461
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine.Funderburg, Nicholas T ; Andrade, Adriana ; Chan, Ellen S ; Rosenkranz, Susan L ; Lu, Darlene ; Clagett, Brian ; Pilch-Cooper, Heather A ; Rodriguez, Benigno ; Feinberg, Judith ; Daar, Eric ; Mellors, John ; Kuritzkes, Daniel ; Jacobson, Jeffrey M ; Lederman, Michael M2013PLoS One128
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.Koelsch, Kersten K ; Liu, Lin ; Haubrich, Richard ; May, Susanne ; Havlir, Diane ; Günthard, Huldrych F ; Ignacio, Caroline C ; Campos-Soto, Paula ; Little, Susan J ; Shafer, Robert ; Robbins, Gregory K ; D'Aquila, Richard T ; Kawano, Yuji ; Young, Karen ; Dao, Phillip ; Spina, Celsa A ; Richman, Douglas D ; Wong, Joseph K2008 Feb 1J Infect Dis3197
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.Kelesidis, Theodoros ; Yang, Otto O ; Kendall, Michelle A ; Hodis, Howard N ; Currier, Judith S2013Lipids Health Dis12
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.Sax, Paul E ; Sloan, Caroline E ; Schackman, Bruce R ; Grant, Philip M ; Rong, Jian ; Zolopa, Andrew R ; Powderly, William ; Losina, Elena ; Freedberg, Kenneth A ; Cepac US And Actg A5164 Investigators2010 Sep-OctHIV Clin Trials511
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.Zolopa, Andrew ; Andersen, Janet ; Powderly, William ; Sanchez, Alejandro ; Sanne, Ian ; Suckow, Carol ; Hogg, Evelyn ; Komarow, Lauren2009PLoS One54
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b).Andrade, Adriana ; Guedj, Jeremie ; Rosenkranz, Susan L ; Lu, Darlene ; Mellors, John ; Kuritzkes, Daniel R ; Perelson, Alan S ; Ribeiro, Ruy M ; ACTG A5249s protocol team2015 Nov 28AIDS1829
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.Grant, Philip M ; Tierney, Camlin ; Budhathoki, Chakra ; Daar, Eric S ; Sax, Paul E ; Collier, Ann C ; Fischl, Margaret A ; Zolopa, Andrew R ; Balamane, Maya ; Katzenstein, David2013 Nov-DecHIV Clin Trials614
Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.Simpson, Kit N ; Dietz, Birgitta ; Baran, Robert W ; Garren, Kevin W ; Riddler, Sharon A ; Bhor, Menaka ; Haubrich, Richard H2011Cost Eff Resour Alloc9
Educational attainment and response to HAART during initial therapy for HIV-1 infection.Marc, Linda G ; Testa, Marcia A ; Walker, Alexander M ; Robbins, Gregroy K ; Shafer, Robert W ; Anderson, Norman B ; Berkman, Lisa F ; ACTG Data Analysis Concept Sheet Study Team2007 AugJ Psychosom Res263
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Podany, Anthony T ; Bao, Yajing ; Swindells, Susan ; Chaisson, Richard E ; Andersen, Janet W ; Mwelase, Thando ; Supparatpinyo, Khuanchai ; Mohapi, Lerato ; Gupta, Amita ; Benson, Constance A ; Kim, Peter ; Fletcher, Courtney V ; AIDS Clinical Trials Group A5279 Study Team2015 Oct 15Clin Infect Dis861
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.Ribaudo, Heather J ; Kuritzkes, Daniel R ; Lalama, Christina M ; Schouten, Jeffrey T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Apr 1J Infect Dis7197
The effect of aging on T-regulatory cell frequency in HIV infection.Tenorio, Allan R ; Spritzler, John ; Martinson, Jeffrey ; Gichinga, Caroline N ; Pollard, Richard B ; Lederman, Michael M ; Kalayjian, Robert C ; Landay, Alan L2009 MarClin Immunol3130
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.Geng, Elvin H ; Kahn, James S ; Chang, Olivia C ; Hare, C Bradley ; Christopoulos, Katerina A ; Jones, Diane ; Petersen, Maya L ; Deeks, Steven G ; Havlir, Diane V ; Gandhi, Monica2011 NovClin Infect Dis1053
Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.Stapleton, J T ; Bennett, K ; Bosch, R J ; Polgreen, P M ; Swindells, S2007 Nov-DecHIV Clin Trials68
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.Gandhi, Rajesh T ; Spritzler, John ; Chan, Ellen ; Asmuth, David M ; Rodriguez, Benigno ; Merigan, Thomas C ; Hirsch, Martin S ; Shafer, Robert W ; Robbins, Gregory K ; Pollard, Richard B ; ACTG 384 Team2006 Aug 1J Acquir Immune Defic Syndr442
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.Jacobson, Jeffrey M ; Bosinger, Steven E ; Kang, Minhee ; Belaunzaran-Zamudio, Pablo ; Matining, Roy M ; Wilson, Cara C ; Flexner, Charles ; Clagett, Brian ; Plants, Jill ; Read, Sarah ; Purdue, Lynette ; Myers, Laurie ; Boone, Linda ; Tebas, Pablo ; Kumar, Princy ; Clifford, David ; Douek, Daniel ; Silvestri, Guido ; Landay, Alan L ; Lede2016 JulAIDS Res Hum Retroviruses732
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.Acosta, Edward P ; Kendall, Michelle A ; Gerber, John G ; Alston-Smith, Beverly ; Koletar, Susan L ; Zolopa, Andrew R ; Agarwala, Sangeeta ; Child, Michael ; Bertz, Richard ; Hosey, Lara ; Haas, David W2007 SepAntimicrob Agents Chemother951
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.Ribaudo, Heather J ; Liu, Huan ; Schwab, Matthias ; Schaeffeler, Elke ; Eichelbaum, Michel ; Motsinger-Reif, Alison A ; Ritchie, Marylyn D ; Zanger, Ulrich M ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David ; Haas, David W2010 Sep 1J Infect Dis5202
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Weinberg, Adriana ; Park, Jeong-Gun ; Bosch, Ronald ; Cho, Alice ; Livingston, Elizabeth ; Aweeka, Fran ; Cramer, Yoninah ; Watts, D Heather ; Luque, Amneris E ; Cohn, Susan E2016 Feb 1J Acquir Immune Defic Syndr271
Effect of early versus deferred antiretroviral therapy for HIV on survival.Kitahata, Mari M ; Gange, Stephen J ; Abraham, Alison G ; Merriman, Barry ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Deeks, Steven G ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Grego2009 Apr 30N Engl J Med18360
The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Chew, Kara W ; Hua, Lei ; Bhattacharya, Debika ; Butt, Adeel A ; Bornfleth, Lorelei ; Chung, Raymond T ; Andersen, Janet W ; Currier, Judith S2014 DecOpen Forum Infect Dis31
Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.Twigg Iii, Homer L ; Weiden, Michael ; Valentine, Fred ; Schnizlein-Bick, Carol T ; Bassett, Roland ; Zheng, Lu ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Collman, Ronald G ; Fox, Lawrence ; Brizz, Barbara ; Dragavon, Joan ; Coombs, Robert W ; Bucy, R Pat ; AIDS Clinical Trials Group Protocol 723 Team2008 Jan 1J Infect Dis1197
Effect of HIV-1 infection on human DNA yield from saliva.Basham, Rebecca J ; Richardson, Danielle M ; Sutcliffe, Cara B ; Haas, David W2009 Jul-AugHIV Clin Trials410
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.Bakshi, Rahul P ; Hamzeh, Fayez ; Frank, Ian ; Eron, Joseph J ; Bosch, Ronald J ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Ussery, Michael ; Flexner, Charles2007 NovAIDS Res Hum Retroviruses1123
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.Eron, Joseph J ; Bosch, Ronald J ; Bettendorf, Daniel ; Petch, Leslie ; Fiscus, Susan ; Frank, Ian ; Adult Clinical Trials Group 307 Protocol Team2007 Jun 1J Acquir Immune Defic Syndr245
Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients.Velilla, P A ; Shata, M T ; Lages, C S ; Ying, J ; Fichtenbaum, C J ; Chougnet, C2008 JanAIDS Res Hum Retroviruses124
Effect of low-dose ritonavir on the pharmacokinetics of the CXCR4 antagonist AMD070 in healthy volunteers.Cao, Ying Jun ; Flexner, Charles W ; Dunaway, Shelia ; Park, Jeong-Gun ; Klingman, Karin ; Wiggins, Ilene ; Conley, Jeanne ; Radebaugh, Christine ; Kashuba, Angela D ; MacFarland, Ron ; Becker, Stephen ; Hendrix, Craig W2008 MayAntimicrob Agents Chemother552
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.Gandhi, Rajesh T ; Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Palmer, Sarah ; Medvik, Kathy ; Lederman, Michael M ; Alatrakchi, Nadia ; Jacobson, Jeffrey M ; Wiegand, Ann ; Kearney, Mary ; Coffin, John M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group A5244 team2010PLoS Med87
Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness.Hu, Zixin ; Kuritzkes, Daniel R2010 OctJ Acquir Immune Defic Syndr255
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.Overton, E T ; Kitch, D ; Benson, C A ; Hunt, P W ; Stein, J H ; Smurzynski, M ; Ribaudo, H J ; Tebas, P2013 MayClin Infect Dis1056
Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.Clifford, D B ; Smurzynski, M ; Park, L S ; Yeh, T-M ; Zhao, Y ; Blair, L ; Arens, M ; Evans, S R2009 Jul 28Neurology473
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.Smurzynski, Marlene ; Wu, Kunling ; Letendre, Scott ; Robertson, Kevin ; Bosch, Ronald J ; Clifford, David B ; Evans, Scott ; Collier, Ann C ; Taylor, Michael ; Ellis, Ronald2011 Jan 28AIDS325
Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.Blackard, Jason T ; Kang, Minhee ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Chung, Raymond T2006 NovJ Interferon Cytokine Res1126
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.Gupta, Samir K ; Smurzynski, Marlene ; Franceschini, Nora ; Bosch, Ronald J ; Szczech, Lynda A ; Kalayjian, Robert C ; AIDS Clinical Trials Group Longitudinal Linked Randomized Trials Study Team2009Antivir Ther414
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.Mulligan, Kathleen ; Yang, Yang ; Wininger, David A ; Koletar, Susan L ; Parker, Robert A ; Alston-Smith, Beverly L ; Schouten, Jeffrey T ; Fielding, Roger A ; Basar, Michael T ; Grinspoon, Steven2007 Jan 2AIDS121
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients.Bedimo, Roger ; Kang, Minhee ; Tebas, Pablo ; Overton, Edgar T ; Hollabaugh, Kimberly ; McComsey, Grace ; Bhattacharya, Debika ; Evans, Christopher ; Brown, Todd T ; Taiwo, Babafemi2016 AprAIDS Res Hum Retroviruses432
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.Dubé, Michael P ; Parker, Robert A ; Mulligan, Kathleen ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Grinspoon, Steven K2007 Jul 1Clin Infect Dis145
Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.Bhasin, Shalender ; Parker, Robert A ; Sattler, Fred ; Haubrich, Richard ; Alston, Beverly ; Umbleja, Triin ; Shikuma, Cecilia M ; AIDS Clinical Trials Group Protocol A5079 Study Team2007 MarJ Clin Endocrinol Metab392
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, N ; Flanigan, Timothy ; Klingman, Karin L ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; Lalloo, Umesh ; Riviere, Cynthia ; Sanchez, Jorge ; Melo, Marineide ; Supparatpinyo, Khuanchai ; Tripathy, Srikanth ; Martinez, Ana I ; Nair, Apsara ; Walawa2012PLoS Med89
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.Lennox, Jeffrey L ; Landovitz, Raphael J ; Ribaudo, Heather J ; Ofotokun, Ighovwerha ; Na, Lumine H ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Sagar, Manish ; Brown, Todd T ; Cohn, Susan E ; McComsey, Grace A ; Aweeka, Francesca ; Fichtenbaum, Carl J ; Presti, Rachel M ; Koletar, Susan L ; Haas, David W ; Patterson, Kristine B ; Benson, 2014 Oct 7Ann Intern Med7161
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).Taiwo, Babafemi ; Zheng, Lu ; Gallien, Sebastien ; Matining, Roy M ; Kuritzkes, Daniel R ; Wilson, Cara C ; Berzins, Baiba I ; Acosta, Edward P ; Bastow, Barbara ; Kim, Peter S ; Eron, Joseph J ; ACTG A5262 Team2011 Nov 13AIDS1725
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.Grant, Philip M ; Komarow, Lauren ; Lederman, Michael M ; Pahwa, Savita ; Zolopa, Andrew R ; Andersen, Janet ; Asmuth, David M ; Devaraj, Sridevi ; Pollard, Richard B ; Richterman, Aaron ; Kanthikeel, Sudheesh ; Sereti, Irini2012 Dec 1J Infect Dis11206
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.Gallien, Sebastien ; Delaugerre, Constance ; Charreau, Isabelle ; Braun, Joséphine ; Boulet, Thomas ; Barrail-Tran, Aurélie ; de Castro, Nathalie ; Molina, Jean-Michel ; Kuritzkes, Daniel R2011 Mar 13AIDS525
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.Hosseinipour, Mina C ; Bisson, Gregory P ; Miyahara, Sachiko ; Sun, Xin ; Moses, Agnes ; Riviere, Cynthia ; Kirui, Fredrick K ; Badal-Faesen, Sharlaa ; Lagat, David ; Nyirenda, Mulinda ; Naidoo, Kogieleum ; Hakim, James ; Mugyenyi, Peter ; Henostroza, German ; Leger, Paul D ; Lama, Javier R ; Mohapi, Lerato ; Alave, Jorge ; Mave, Vidya ; V2016 Mar 19Lancet10024387
Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.Torriani, Francesca J ; Komarow, Lauren ; Parker, Robert A ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Stein, James H ; ACTG 5152s Study Team2008 Aug 12J Am Coll Cardiol752
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.Labo, Nazzarena ; Miley, Wendell ; Benson, Constance A ; Campbell, Thomas B ; Whitby, Denise2015 Jun 19AIDS1029
Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.Sharkey, Mark ; Babic, Dunja Z ; Greenough, Thomas ; Gulick, Roy ; Kuritzkes, Daniel R ; Stevenson, Mario2011 FebPLoS Pathog27
Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy.Schouten, Jeffrey Thomas ; Schiffer, Joshua T2012 May 1J Acquir Immune Defic Syndr160
European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142.Hulgan, Todd ; Haubrich, Richard ; Riddler, Sharon A ; Tebas, Pablo ; Ritchie, Marylyn D ; McComsey, Grace A ; Haas, David W ; Canter, Jeffrey A2011 Jan 2AIDS125
Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095.Li, Li ; Eron, Joseph J ; Ribaudo, Heather ; Gulick, Roy M ; Johnson, Brent A2012J Am Stat Assoc498107
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.Sattler, Fred R ; Rajicic, Natasa ; Mulligan, Kathleen ; Yarasheski, Kevin E ; Koletar, Susan L ; Zolopa, Andrew ; Alston Smith, Beverly ; Zackin, Robert ; Bistrian, Bruce ; ACTG 392 Study Team2008 NovAm J Clin Nutr588
Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.Li, Jonathan Z ; Christensen, Julie A ; Wang, Hongying ; Spritzler, John ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2012 Sep 1J Acquir Immune Defic Syndr161
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Luetkemeyer, Anne F ; Kendall, Michelle A ; Wu, Xingye ; Lourenço, Maria Cristina ; Jentsch, Ute ; Swindells, Susan ; Qasba, Sarojini S ; Sanchez, Jorge ; Havlir, Diane V ; Grinsztejn, Beatriz ; Sanne, Ian M ; Firnhaber, Cynthia ; Adult AIDS Clinical Trials Group A5255 Study Team2014 AprJ Clin Microbiol452
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.Luetkemeyer, Anne F ; Firnhaber, Cynthia ; Kendall, Michelle A ; Wu, Xingye ; Mazurek, Gerald H ; Benator, Debra A ; Arduino, Roberto ; Fernandez, Michel ; Guy, Elizabeth ; Johnson, Pamela ; Metchock, Beverly ; Sattler, Fred ; Telzak, Edward ; Wang, Yun F ; Weiner, Marc ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Grinsztejn, Beat2016 May 1Clin Infect Dis962
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.Jacobson, Jeffrey M ; Pat Bucy, R ; Spritzler, John ; Saag, Michael S ; Eron, Joseph J ; Coombs, Robert W ; Wang, Rui ; Fox, Lawrence ; Johnson, Victoria A ; Cu-Uvin, Susan ; Cohn, Susan E ; Mildvan, Donna ; O'Neill, Dorothy ; Janik, Jennifer ; Purdue, Lynette ; O'Connor, Deborah K ; Vita, Christine Di ; Frank, Ian ; National Institute of 2006 Sep 1J Infect Dis5194
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.Henrich, Timothy J ; Tsibris, Athe M N ; Lewine, Nicolas R P ; Konstantinidis, Ioannis ; Leopold, Kay E ; Sagar, Manish ; Kuritzkes, Daniel R2010 DecJ Acquir Immune Defic Syndr455
Examining the challenges and solutions to the implementation of trials in resource-limited settings: Limited Resource Trials.Blanchard-Horan, Christina ; Stocker, Vicki ; Moran, Laura ; Ferguson, Elaine Okubo ; Klingman, Karin L ; McMahon, Deborah ; Hitti, Jane2012 Jan 1Appl Clin Trials121
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.Harrison, Taylor ; Miyahara, Sachiko ; Lee, Anthony ; Evans, Scott ; Bastow, Barbara ; Simpson, David ; Gilron, Ian ; Dworkin, Robert ; Daar, Eric S ; Wieclaw, Linda ; Clifford, David B ; ACTG A5252 Team2013 JulPain Med714
Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.Almeida, Coral-Ann M ; Roberts, Steven G ; Laird, Rebecca ; McKinnon, Elizabeth ; Ahmad, Imran ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Heckerman, David ; Mallal, Simon ; John, Mina2010 Aug 23Vaccine3728
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.Chung, Raymond T ; Umbleja, Triin ; Chen, Jennifer Y ; Andersen, Janet W ; Butt, Adeel A ; Sherman, Kenneth E ; Actg A5178 Study Team2012 Mar-AprHIV Clin Trials213
Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.Dubé, Michael P ; Komarow, Lauren ; Fichtenbaum, Carl J ; Cadden, Joseph J ; Overton, Edgar T ; Hodis, Howard N ; Currier, Judith S ; Stein, James H ; AIDS Clinical Trials Group A5293 Study Team2015 Sep 1Clin Infect Dis561
Factors associated with CD8+ T-cell activation in HIV-1-infected patients on long-term antiretroviral therapy.Zheng, Lu ; Taiwo, Babafemi ; Gandhi, Rajesh T ; Hunt, Peter W ; Collier, Ann C ; Flexner, Charles ; Bosch, Ronald J2014 Oct 1J Acquir Immune Defic Syndr267
Factors associated with early study discontinuation in AACTG studies, DACS 200.Andersen, Janet W ; Fass, Robert ; van der Horst, Charles2007 SepContemp Clin Trials528
Factors associated with remaining on initial randomized efavirenz-containing regimens.Smurzynski, Marlene ; Wu, Kunling ; Schouten, Jeffrey T ; Lok, Judith J ; Bosch, Ronald J ; Taiwo, Babafemi ; Johnson, Victoria Anne ; Collier, Ann C2013 Jul 31AIDS1227
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial.Li, Jonathan Z ; Brumme, Zabrina L ; Brumme, Chanson J ; Wang, Hongying ; Spritzler, John ; Robertson, Michael N ; Lederman, Michael M ; Carrington, Mary ; Walker, Bruce D ; Schooley, Robert T ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5197 Study Team2011 Apr 1J Infect Dis7203
Failure of initial therapy with two nucleosides and efavirenz is not associated with early emergence of mutations in the C-terminus of HIV-1 reverse transcriptase.Brehm, Jessica H ; Lalama, Christina M ; Hughes, Michael D ; Haubrich, Richard ; Riddler, Sharon A ; Sluis-Cremer, Nicolas ; Mellors, John W ; AIDS Clinical Trials Group Study A5142 Protocol Team2011 AprJ Acquir Immune Defic Syndr456
A faunistic survey of cercariae isolated from lymnaeid snails in central areas of Mazandaran, Iran.Sharif, M ; Daryani, A ; Karimi, S A2010 Feb 15Pak J Biol Sci413
Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.McLaren, Paul J ; Ripke, Stephan ; Pelak, Kimberly ; Weintrob, Amy C ; Patsopoulos, Nikolaos A ; Jia, Xiaoming ; Erlich, Rachel L ; Lennon, Niall J ; Kadie, Carl M ; Heckerman, David ; Gupta, Namrata ; Haas, David W ; Deeks, Steven G ; Pereyra, Florencia ; Walker, Bruce D ; DE Bakker, Paul I W ; International HIV Controllers Study2012 Oct 1Hum Mol Genet1921
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.Ciaranello, Andrea L ; Lockman, Shahin ; Freedberg, Kenneth A ; Hughes, Michael ; Chu, Jennifer ; Currier, Judith ; Wood, Robin ; Holmes, Charles B ; Pillay, Sandy ; Conradie, Francesca ; McIntyre, James ; Losina, Elena ; Walensky, Rochelle P ; CEPAC-International and OCTANE Investigators2011 Feb 20AIDS425
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.Gerber, John G ; Kitch, Douglas W ; Fichtenbaum, Carl J ; Zackin, Robert A ; Charles, Stéphannie ; Hogg, Evelyn ; Acosta, Edward P ; Connick, Elizabeth ; Wohl, David ; Kojic, E Milu ; Benson, Constance A ; Aberg, Judith A2008 Apr 1J Acquir Immune Defic Syndr447
Fractures after antiretroviral initiation.Yin, Michael T ; Kendall, Michelle A ; Wu, Xingye ; Tassiopoulos, Katherine ; Hochberg, Marc ; Huang, Jeannie S ; Glesby, Marshall J ; Bolivar, Hector ; McComsey, Grace A2012 Nov 13AIDS1726
Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study.Kendall, Michelle A ; Tassiopoulos, Katherine ; McComsey, Grace A ; Yin, Michael T2015 AugAIDS Res Hum Retroviruses831
Frequency of Antiretroviral Resistance Mutations among Infants Exposed to Single-Dose Nevirapine and Short Course Maternal Antiretroviral Regimens: ACTG A5207.Hitti, Jane ; Halvas, Elias K ; Zheng, Lu ; Panousis, Constantinos G ; Kabanda, Joseph ; Taulo, Frank ; Kumarasamy, Nagalingeswaran ; Pape, Jean William ; Lalloo, Umesh ; Sprenger, Heather ; Klingman, Karin L ; Chan, Ellen S ; McMahon, Deborah ; Mellors, John W2014 NovJ AIDS Clin Res115
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.Skinner-Adams, Tina S ; Butterworth, Alice S ; Porter, Kimberly A ; D'Amico, Ronald ; Sawe, Fred ; Shaffer, Doug ; Siika, Abraham ; Hosseinipour, Mina C ; Stringer, Elizabeth ; Currier, Judith S ; Chipato, Tsungai ; Salata, Robert ; Lockman, Shahin ; Eron, Joseph J ; Meshnick, Steven R ; McCarthy, James S2012PLoS One47
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.Schwarze-Zander, Carolynne ; Blackard, Jason T ; Zheng, Hui ; Addo, Marylyn M ; Lin, Wenyu ; Robbins, Gregory K ; Sherman, Kenneth E ; Zdunek, Dietmar ; Hess, Georg ; Chung, Raymond T ; AIDS Clinical Trial Group A5071 Study Team2006 Aug 15J Infect Dis4194
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.Stapleton, Jack T ; Chaloner, Kathryn ; Zhang, Jingyang ; Klinzman, Donna ; Souza, Inara E ; Xiang, Jinhua ; Landay, Alan ; Fahey, John ; Pollard, Richard ; Mitsuyasu, Ronald2009 Mar 13AIDS523
Genetic analysis implicates resistin in HIV lipodystrophy.Ranade, Koustubh ; Geese, William J ; Noor, Mustafa ; Flint, Oliver ; Tebas, Pablo ; Mulligan, Kathleen ; Powderly, William ; Grinspoon, Steven K ; Dubé, Michael P2008 Aug 20AIDS1322
Genetic attributes of cerebrospinal fluid-derived HIV-1 env.Pillai, Satish K ; Pond, Sergei L Kosakovsky ; Liu, Yang ; Good, Benjamin M ; Strain, Matthew C ; Ellis, Ronald J ; Letendre, Scott ; Smith, Davey M ; Günthard, Huldrych F ; Grant, Igor ; Marcotte, Thomas D ; McCutchan, J Allen ; Richman, Douglas D ; Wong, Joseph K2006 JulBrainPt 7129
Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Cespedes, Michelle S ; Kerns, Sarah L ; Holzman, Robert S ; McLaren, Paul J ; Ostrer, Harry ; Aberg, Judith A2013 Nov-DecHIV Clin Trials614
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.Bartha, István ; Carlson, Jonathan M ; Brumme, Chanson J ; McLaren, Paul J ; Brumme, Zabrina L ; John, Mina ; Haas, David W ; Martinez-Picado, Javier ; Dalmau, Judith ; López-Galíndez, Cecilio ; Casado, Concepción ; Rauch, Andri ; Günthard, Huldrych F ; Bernasconi, Enos ; Vernazza, Pietro ; Klimkait, Thomas ; Yerly, Sabine ; O'Brien, Steph2013Elife2
Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.Johnson, Daniel H ; Venuto, Charles ; Ritchie, Marylyn D ; Morse, Gene D ; Daar, Eric S ; McLaren, Paul J ; Haas, David W2014 AprPharmacogenet Genomics424
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.Henrich, Timothy J ; McLaren, Paul J ; Rao, Suhas S P ; Lin, Nina H ; Hanhauser, Emily ; Giguel, Francoise ; Gulick, Roy M ; Ribaudo, Heather ; DE Bakker, Paul I W ; Kuritzkes, Daniel R2014 MarOpen Forum Infect Dis11
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Leger, Paul D ; Johnson, Daniel H ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Li, Jun ; McLaren, Paul J ; Haas, David W2014 JunJ Neurovirol320
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.Holzinger, Emily R ; Grady, Benjamin ; Ritchie, Marylyn D ; Ribaudo, Heather J ; Acosta, Edward P ; Morse, Gene D ; Gulick, Roy M ; Robbins, Gregory K ; Clifford, David B ; Daar, Eric S ; McLaren, Paul ; Haas, David W2012 DecPharmacogenet Genomics1222
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.Wanga, Valentine ; Venuto, Charles ; Morse, Gene D ; Acosta, Edward P ; Daar, Eric S ; Haas, David W ; Li, Chun ; Shepherd, Bryan E2015 SepPharmacogenet Genomics925
Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.Lehmann, David S ; Ribaudo, Heather J ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard H ; Robbins, Gregory K ; DE Bakker, Paul I W ; Haas, David W ; McLaren, Paul J2015 FebPharmacogenet Genomics225
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.Lorenzana, Sarah B ; Hughes, Michael D ; Grinsztejn, Beatriz ; Collier, Ann C ; Luz, Paula Mendes ; Freedberg, Kenneth A ; Wood, Robin ; Levison, Julie H ; Mugyenyi, Peter N ; Salata, Robert ; Wallis, Carole L ; Weinstein, Milton C ; Schooley, Robert T ; Walensky, Rochelle P2012 Jun 1AIDS926
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.Anderson, Jeffrey A ; Jiang, Hongyu ; Ding, Xiao ; Petch, Leslie ; Journigan, Terri ; Fiscus, Susan A ; Haubrich, Richard ; Katzenstein, David ; Swanstrom, Ronald ; Gulick, Roy M ; AIDS Clinical Trials Group Study 359 Protocol Team2008 MayAIDS Res Hum Retroviruses524
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.McMahon, Deborah K ; Zheng, Lu ; Hitti, Jane ; Chan, Ellen S ; Halvas, Elias K ; Hong, Feiyu ; Kabanda, Joseph ; Taulo, Frank ; Kumarasamy, Nagalingeswaran ; Bonhomme, Jerry ; Wallis, Carole L ; Klingman, Karin L ; Hughes, Michael D ; Mellors, John W2013 AprClin Infect Dis756
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?Abu-Raddad, Laith J ; Barnabas, Ruanne V ; Janes, Holly ; Weiss, Helen A ; Kublin, James G ; Longini, Ira M ; Wasserheit, Judith N ; HIV Viral Load Working Group2013 Mar 27AIDS627
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.Kemmer, N ; Hua, L ; Andersen, J W ; Chung, R T ; Butt, A A ; Sherman, K E ; ACTG 5178 Study Team2012 NovJ Viral Hepat1119
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.Behler, Caroline M ; Vittinghoff, Eric ; Lin, Feng ; Chung, Raymond T ; Peters, Marion G ; Robbins, Gregory K ; Volberding, Paul A2007 May 15Clin Infect Dis1044
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.Hulgan, Todd ; Tebas, Pablo ; Canter, Jeffrey A ; Mulligan, Kathleen ; Haas, David W ; Dubé, Michael ; Grinspoon, Steven ; Robbins, Gregory K ; Motsinger, Alison A ; Kallianpur, Asha R ; AIDS Clinical Trials Group 384 and A5005s Study Teams2008 Mar 15J Infect Dis6197
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.Kallianpur, Asha R ; Hulgan, Todd ; Canter, Jeffrey A ; Ritchie, Marylyn D ; Haines, Jonathan L ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; Haas, David W2006 Jul 13AIDS1120
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.Cramer, Yoninah S ; Rosenkranz, Susan L ; Hall, Stephen D ; Szczech, Lynda A ; Amorosa, Valerianna ; Gupta, Samir K2010 AugJ Acquir Immune Defic Syndr454
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.Sherman, Kenneth E ; Rouster, Susan D ; Stanford, Sandra ; Blackard, Jason T ; Shire, Norah ; Koziel, Margaret ; Peters, Marion ; Chung, Raymond T ; AIDS Clinical Trials Group 5071 Study Team2010 MarJ Infect Dis5201
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Hua, Lei ; Andersen, Janet W ; Daar, Eric S ; Glesby, Marshall J ; Hollabaugh, Kimberly ; Tierney, Camlin2013 Nov 13AIDS1727
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.Haas, David W ; Koletar, Susan L ; Laughlin, Laura ; Kendall, Michelle A ; Suckow, Carol ; Gerber, John G ; Zolopa, Andrew R ; Bertz, Richard ; Child, Michael J ; Hosey, Lara ; Alston-Smith, Beverly ; Acosta, Edward P ; A5213 StudyTeam2009 Mar 1J Acquir Immune Defic Syndr350
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.Cachay, Edward R ; Frost, Simon D W ; Richman, Douglas D ; Smith, Davey M ; Little, Susan J2007 May 1J Infect Dis9195
Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses.Healy, Brian ; Degruttola, Victor2007 AprBiostatistics28
Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system.Huang, Yangxin ; Liu, Dacheng ; Wu, Hulin2006 JunBiometrics262
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.Shiboski, Caroline H ; Chen, Huichao ; Secours, Rode ; Lee, Anthony ; Webster-Cyriaque, Jennifer ; Ghannoum, Mahmoud ; Evans, Scott ; Bernard, Daphné ; Reznik, David ; Dittmer, Dirk P ; Hosey, Lara ; Severe, Patrice ; Aberg, Judith A ; Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group2015PLoS One710
High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.Keane, Niamh M ; Roberts, Steven G ; Almeida, Coral-Ann M ; Krishnan, Tanya ; Chopra, Abha ; Demaine, Emma ; Laird, Rebecca ; Tschochner, Monika ; Carlson, Jonathan M ; Mallal, Simon ; Heckerman, David ; James, Ian ; John, Mina2012 FebImmunol Cell Biol290
Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication.Chang, J Judy ; Woods, Matt ; Lindsay, Robert J ; Doyle, Erin H ; Griesbeck, Morgane ; Chan, Ellen S ; Robbins, Gregory K ; Bosch, Ronald J ; Altfeld, Marcus2013 Sep 1J Infect Dis5208
High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.Wilkin, Timothy ; Lee, Jeannette Y ; Lensing, Shelly Y ; Stier, Elizabeth A ; Goldstone, Stephen E ; Berry, Michael J ; Jay, Naomi ; Aboulafia, David M ; Einstein, Mark H ; Saah, Alfred ; Mitsuyasu, Ronald T ; Palefsky, Joel M2013 Mar-AprHIV Clin Trials214
High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.Fichtenbaum, Carl J ; Evans, Scott E ; Aberg, Judith A2011 Oct 23AIDS1625
HIV and aging.Shah, Sanjiv ; Mildvan, Donna2006 MayCurr Infect Dis Rep38
HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells.Yonkers, Nicole L ; Rodriguez, Benigno ; Post, Anthony B ; Asaad, R ; Jones, Linda ; Lederman, Michael M ; Lehmann, Paul V ; Anthony, Donald D2006 Aug 1J Infect Dis3194
HIV drug development: the next 25 years.Flexner, Charles2007 DecNat Rev Drug Discov126
HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes.Bronke, Corine ; Almeida, Coral-Ann M ; McKinnon, Elizabeth ; Roberts, Steven G ; Keane, Niamh M ; Chopra, Abha ; Carlson, Jonathan M ; Heckerman, David ; Mallal, Simon ; John, Mina2013 Mar 27AIDS627
HIV neuropathy natural history cohort study: assessment measures and risk factors.Simpson, D M ; Kitch, D ; Evans, S R ; McArthur, J C ; Asmuth, D M ; Cohen, B ; Goodkin, K ; Gerschenson, M ; So, Y ; Marra, C M ; Diaz-Arrastia, R ; Shriver, S ; Millar, L ; Clifford, D B ; ACTG A5117 Study Group2006 Jun 13Neurology1166
HIV peripheral neuropathy progression: protection with glucose-lowering drugs?Evans, Scott R ; Lee, Anthony J ; Ellis, Ronald J ; Chen, Huichao ; Wu, Kunling ; Bosch, Ronald J ; Clifford, David B2012 OctJ Neurovirol518
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.Tashima, Karen T ; Smeaton, Laura M ; Fichtenbaum, Carl J ; Andrade, Adriana ; Eron, Joseph J ; Gandhi, Rajesh T ; Johnson, Victoria A ; Klingman, Karin L ; Ritz, Justin ; Hodder, Sally ; Santana, Jorge L ; Wilkin, Timothy ; Haubrich, Richard H ; A5241 Study Team2015 Dec 15Ann Intern Med12163
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.McCutchan, J Allen ; Wu, Julia W ; Robertson, Kevin ; Koletar, Susan L ; Ellis, Ronald J ; Cohn, Susan ; Taylor, Michael ; Woods, Steven ; Heaton, Robert ; Currier, Judith ; Williams, Paige L2007 May 31AIDS921
HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States.Landovitz, Raphael J ; Tran, Thuy Tien T ; Cohn, Susan E ; Ofotokun, Ighovwhera ; Godfrey, Catherine ; Kuritzkes, Daniel R ; Lennox, Jeffrey L ; Currier, Judith S ; Ribaudo, Heather J2016 Mar 16AIDS Behav
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.Mollan, Katie ; Daar, Eric S ; Sax, Paul E ; Balamane, Maya ; Collier, Ann C ; Fischl, Margaret A ; Lalama, Christina M ; Bosch, Ronald J ; Tierney, Camlin ; Katzenstein, David ; AIDS Clinical Trials Group Study A5202 Team2012 Dec 15J Infect Dis12206
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.Putcharoen, Opass ; Lee, Sun Hee ; Henrich, Timothy J ; Hu, Zixin ; Vanichanan, Jakapat ; Coakley, Eoin ; Greaves, Wayne ; Gulick, Roy M ; Kuritzkes, Daniel R ; Tsibris, Athe M N2012 JanJ Virol286
HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.Besson, Guillaume J ; Lalama, Christina M ; Bosch, Ronald J ; Gandhi, Rajesh T ; Bedison, Margaret A ; Aga, Evgenia ; Riddler, Sharon A ; McMahon, Deborah K ; Hong, Feiyu ; Mellors, John W2014 Nov 1Clin Infect Dis959
HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.Mitsuya, Yumi ; Winters, Mark A ; Fessel, W Jeffrey ; Rhee, Soo-Yon ; Slome, Sally ; Flamm, Jason ; Horberg, Michael ; Hurley, Leo ; Klein, Daniel ; Shafer, Robert W2006 SepJ Acquir Immune Defic Syndr143
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.Rhee, Soo-Yon ; Kantor, Rami ; Katzenstein, David A ; Camacho, Ricardo ; Morris, Lynn ; Sirivichayakul, Sunee ; Jorgensen, Louise ; Brigido, Luis F ; Schapiro, Jonathan M ; Shafer, Robert W ; International Non Subtype B HIV-1 Working Group2006 Mar 21AIDS520
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study.Porter, Kimberly A ; Cole, Stephen R ; Eron, Joseph J ; Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Poole, Charles ; Skinner-Adams, Tina S ; Hosseinipour, Mina ; Shaffer, Doug ; D'Amico, Ronald ; Sawe, Frederick K ; Siika, Abraham ; Stringer, Elizabeth ; Currier, Judith S ; Chipato, Tsungai ; Salata, Robert ; McCarthy, James S ; Mesh2012 FebAntimicrob Agents Chemother256
HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.Kantor, Rami ; Bettendorf, Daniel ; Bosch, Ronald J ; Mann, Marita ; Katzenstein, David ; Cu-Uvin, Susan ; D'Aquila, Richard ; Frenkel, Lisa ; Fiscus, Susan ; Coombs, Robert ; ACTG A5077 Study Team2014PLoS One49
HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.Imamichi, Hiromi ; Degray, Gerald ; Asmuth, David M ; Fischl, Margaret A ; Landay, Alan L ; Lederman, Michael M ; Sereti, Irini2011 Jan 14AIDS225
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.Hubbard, Jonathan J ; Greenwell-Wild, Teresa ; Barrett, Lisa ; Yang, Jun ; Lempicki, Richard A ; Wahl, Sharon M ; Asmuth, David M ; Murphy, Robert L ; Pollard, Richard B ; Kottilil, Shyam2012 May 1J Infect Dis9205
Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.Lee, Sulggi A ; Mefford, Joel A ; Huang, Yong ; Witte, John S ; Martin, Jeffrey N ; Haas, David W ; McLaren, Paul J ; Mushiroda, Taisei ; Kubo, Michiaki ; Byakwaga, Helen ; Hunt, Peter W ; Kroetz, Deanna L2016 Jul 17AIDS1130
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.Funderburg, Nicholas ; Lederman, Michael M ; Feng, Zhimin ; Drage, Michael G ; Jadlowsky, Julie ; Harding, Clifford V ; Weinberg, Aaron ; Sieg, Scott F2007 Nov 20Proc Natl Acad Sci U S A47104
Human genetic variability and HIV treatment response.Haas, David W2006 JulCurr HIV/AIDS Rep23
Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Vardhanabhuti, Saran ; Katzenstein, David ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Wallis, Carole L2016 SepOpen Forum Infect Dis33
Human papillomavirus infection in the oral cavity of HIV patients is not reduced by initiating antiretroviral therapy.Shiboski, Caroline H ; Lee, Anthony ; Chen, Huichao ; Webster-Cyriaque, Jennifer ; Seaman, Todd ; Landovitz, Raphael J ; John, Malcolm ; Reilly, Nancy ; Naini, Linda ; Palefsky, Joel ; Jacobson, Mark A2016 Jun 19AIDS1030
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.Matoga, Mitch M ; Hosseinipour, Mina C ; Aga, Evgenia ; Ribaudo, Heather J ; Kumarasamy, Nagalingeswaran ; Bartlett, John ; Hughes, Michael D ; ACTG A5230 Study Team2016 Oct 14Antivir Ther
IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease.Price, Patricia ; James, Ian2009 Jun 1AIDS923
IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.Sereti, Irini ; Dunham, Richard M ; Spritzler, John ; Aga, Evgenia ; Proschan, Michael A ; Medvik, Kathy ; Battaglia, Catherine A ; Landay, Alan L ; Pahwa, Savita ; Fischl, Margaret A ; Asmuth, David M ; Tenorio, Allan R ; Altman, John D ; Fox, Lawrence ; Moir, Susan ; Malaspina, Angela ; Morre, Michel ; Buffet, Renaud ; Silvestri, Guido ;2009 Jun 18Blood25113
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa.Cimbro, Raffaello ; Vassena, Lia ; Arthos, James ; Cicala, Claudia ; Kehrl, John H ; Park, Chung ; Sereti, Irini ; Lederman, Michael M ; Fauci, Anthony S ; Lusso, Paolo2012 Sep 27Blood13120
Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment.Zhang, Xinyan ; Hunt, Peter W ; Hammer, Scott M ; Cespedes, Michelle S ; Patterson, Kristine B ; Bosch, Ronald J2013 Mar-AprHIV Clin Trials214
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.Overton, E T ; Kang, M ; Peters, M G ; Umbleja, T ; Alston-Smith, B L ; Bastow, B ; Demarco-Shaw, D ; Koziel, M J ; Mong-Kryspin, L ; Sprenger, H L ; Yu, J Y ; Aberg, J A2010 Aug 2Vaccine3428
Immune surveillance in multiple sclerosis patients treated with natalizumab.Stüve, Olaf ; Marra, Christina M ; Jerome, Keith R ; Cook, Linda ; Cravens, Petra D ; Cepok, Sabine ; Frohman, Elliot M ; Phillips, J Theodore ; Arendt, Gabriele ; Hemmer, Bernhard ; Monson, Nancy L ; Racke, Michael K2006 MayAnn Neurol559
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.Haas, David W ; Geraghty, Daniel E ; Andersen, Janet ; Mar, Jessica ; Motsinger, Alison A ; D'Aquila, Richard T ; Unutmaz, Derya ; Benson, Constance A ; Ritchie, Marylyn D ; Landay, Alan ; AIDS Clinical Trials Group2006 Oct 15J Infect Dis8194
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.Kojic, Erna Milunka ; Kang, Minhee ; Cespedes, Michelle S ; Umbleja, Triin ; Godfrey, Catherine ; Allen, Reena T ; Firnhaber, Cynthia ; Grinsztejn, Beatriz ; Palefsky, Joel M ; Webster-Cyriaque, Jennifer Y ; Saah, Alfred ; Aberg, Judith A ; Cu-Uvin, Susan2014 Jul 1Clin Infect Dis159
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.Lok, Judith J ; Hunt, Peter W ; Collier, Ann C ; Benson, Constance A ; Witt, Mallory D ; Luque, Amneris E ; Deeks, Steven G ; Bosch, Ronald J2013 Aug 24AIDS1327
Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy.Cillo, Anthony R ; Krishnan, Supriya ; McMahon, Deborah K ; Mitsuyasu, Ronald T ; Para, Michael F ; Mellors, John W2014PLoS One39
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.Marra, Christina M ; Zhao, Yu ; Clifford, David B ; Letendre, Scott ; Evans, Scott ; Henry, Katherine ; Ellis, Ronald J ; Rodriguez, Benigno ; Coombs, Robert W ; Schifitto, Giovanni ; McArthur, Justin C ; Robertson, Kevin ; AIDS Clinical Trials Group 736 Study Team2009 Jul 17AIDS1123
The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort.Linas, B P ; Wang, B ; Smurzynski, M ; Losina, E ; Bosch, R J ; Schackman, B R ; Rong, J ; Sax, P E ; Walensky, R P ; Schouten, J ; Freedberg, K A2011 JulJ Viral Hepat718
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment.Sacktor, Ned ; Miyahara, Sachiko ; Evans, Scott ; Schifitto, Giovanni ; Cohen, Bruce ; Haughey, Norman ; Drewes, Julia L ; Graham, David ; Zink, M Christine ; Anderson, Caroline ; Nath, Avindra ; Pardo, Carlos A ; McCarthy, Sean ; Hosey, Lara ; Clifford, David ; ACTG A5235 team2014 DecJ Neurovirol620
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Kozal, Michael J ; Svarovskaia, Evguenia S ; Johnson, Jeffrey A ; Geretti, Anna Maria ; Metzner, Karin J ; Jakobsen, Martin R ; Hullsiek, Katherine Huppler ; Ostergaard, Lars ; Miller, Michael D ; Kuritzkes, Daniel R2013 Mar 15J Infect Dis6207
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Butt, Adeel A ; Umbleja, Triin ; Andersen, Janet W ; Sherman, Kenneth E ; Chung, Raymond T ; Actg A5178 Study Team2012 SepClin Infect Dis555
Impact of randomized antiretroviral therapy initiation on glucose metabolism.Erlandson, Kristine Mace ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Melbourne, Kathleen M ; Ha, Belinda ; McComsey, Grace A2014 Jun 19AIDS1028
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine.Aweeka, Francesca T ; Rosenkranz, Susan L ; Segal, Yoninah ; Coombs, Robert W ; Bardeguez, Arlene ; Thevanayagam, Lourdes ; Lizak, Patricia ; Aberg, Judith ; Watts, D Heather ; NIAID AIDS Clinical Trials Group2006 Sep 11AIDS1420
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.Ribaudo, Heather J ; Daar, Eric S ; Tierney, Camlin ; Morse, Gene D ; Mollan, Katie ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Haas, David W ; DS Clinical Trials Group2013 Feb 1J Infect Dis3207
Implementation of HIV-related clinical research in the international setting.Godfrey, Catherine ; Schouten, Jeffrey T ; Swindells, Susan2014 Jan 1J Acquir Immune Defic Syndr65 Suppl 1
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170.Skiest, Daniel J ; Krambrink, Amy ; Su, Zhaohui ; Robertson, Kevin R ; Margolis, David M ; A5170 Study Team2008 Dec 1J Acquir Immune Defic Syndr449
Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.Robertson, K ; Jiang, H ; Kumwenda, J ; Supparatpinyo, K ; Evans, S ; Campbell, T B ; Price, R ; Tripathy, S ; Kumarasamy, N ; La Rosa, A ; Santos, B ; 5199 study team ; Silva, M T ; Montano, S ; Kanyama, C ; Faesen, S ; Murphy, R ; Hall, C ; Marra, C M ; Marcus, C ; Berzins, B ; Allen, R ; Housseinipour, M ; Amod, F ; Sanne, I ; Hakim, J 2012 SepClin Infect Dis655
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution.Williams, Pl ; Wu, Jw ; Cohn, Se ; Koletar, Sl ; McCutchan, Ja ; Murphy, Rl ; Currier, Js ; AIDS Clinical Trials Group 362 Study Team2009 MayHIV Med510
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria.Kshirsagar, Smita A ; Blaschke, Terrence F ; Sheiner, Lewis B ; Krygowski, M ; Acosta, Edward P ; Verotta, Davide2007 FebJ Pharmacokinet Pharmacodyn134
Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks.Godfrey, Catherine C ; Michelow, Pamela M ; Godard, Mandana ; Sahasrabuddhe, Vikrant V ; Darden, Janice ; Firnhaber, Cynthia S ; Wetherall, Neal T ; Bremer, James ; Coombs, Robert W ; Wilkin, Timothy ; A5282 Study Team2013 DecAm J Clin Pathol6140
Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection.Shire, Norah J ; Rao, Marepalli B ; Succop, Paul ; Buncher, C Ralph ; Andersen, Janet A ; Butt, Adeel A ; Chung, Raymond T ; Sherman, Kenneth E ; AIDS Clinical Trials Group 5178 Study Group2009 AprClin Gastroenterol Hepatol47
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.Branch, Andrea D ; Kang, Minhee ; Hollabaugh, Kimberly ; Wyatt, Christina M ; Chung, Raymond T ; Glesby, Marshall J2013 AugAm J Clin Nutr298
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.Tsibris, Athe M N ; Sagar, Manish ; Gulick, Roy M ; Su, Zhaohui ; Hughes, Michael ; Greaves, Wayne ; Subramanian, Mani ; Flexner, Charles ; Giguel, Francoise ; Leopold, Kay E ; Coakley, Eoin ; Kuritzkes, Daniel R2008 AugJ Virol1682
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.Krishnan, Supriya ; Schouten, Jeffrey T ; Jacobson, Denise L ; Benson, Constance A ; Collier, Ann C ; Koletar, Susan L ; Santana, Jorge ; Sattler, Fred R ; Mitsuyasu, Ronald ; ACTG-ALLRT Protocol Team2011Oncology1-280
The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirin.Butt, A A ; Umbleja, T ; Andersen, J W ; Chung, R T ; Sherman, K E ; Actg A5178 Study Team2011 JunAliment Pharmacol Ther1133
Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.Krishnan, S ; Wu, K ; Smurzynski, M ; Bosch, R J ; Benson, C A ; Collier, A C ; Klebert, M K ; Feinberg, J ; Koletar, S L ; ALLRT/A5001 Team2011 Jul-AugHIV Clin Trials412
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.Taylor, Lynn E ; Holubar, Marisa ; Wu, Kunling ; Bosch, Ronald J ; Wyles, David L ; Davis, John A ; Mayer, Kenneth H ; Sherman, Kenneth E ; Tashima, Karen T2011 Mar 15Clin Infect Dis652
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.Robbins, Gregory K ; Spritzler, John G ; Chan, Ellen S ; Asmuth, David M ; Gandhi, Rajesh T ; Rodriguez, Benigno A ; Skowron, Gail ; Skolnik, Paul R ; Shafer, Robert W ; Pollard, Richard B ; AIDS Clinical Trials Group 384 Team2009 Feb 1Clin Infect Dis348
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.McComsey, Grace A ; Kang, Minhee ; Ross, Allison C ; Lebrecht, Dirk ; Livingston, Elizabeth ; Melvin, Ann ; Hitti, Jane ; Cohn, Susan E ; Walker, Ulrich A ; AIDS Clinical Trials Group A50842008 Mar-AprHIV Clin Trials29
Infant outcomes after maternal antiretroviral exposure in resource-limited settings.Nielsen-Saines, Karin ; Komarow, Lauren ; Cu-Uvin, Susan ; Jourdain, Gonzague ; Klingman, Karin L ; Shapiro, David E ; Mofenson, Lynne ; Moran, Laura ; Campbell, Thomas B ; Hitti, Jane ; Fiscus, Susan ; Currier, Judith ; ACTG 5190/PACTG 1054 Study Team2012 JunPediatrics6129
Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.Mave, Vidya ; Erlandson, Kristine M ; Gupte, Nikhil ; Balagopal, Ashwin ; Asmuth, David M ; Campbell, Thomas B ; Smeaton, Laura ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Santos, Breno ; Riviere, Cynthia ; Hosseinipour, Mina C ; Sugandhavesa, Patcharaphan ; Infante, Rosa ; Pillay, Sandy ; Cardoso, Sandra W ; Tripathy, Srikanth ; Mwelas2016 Jul 1J Infect Dis1214
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.McComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Sax, Paul E2012 Jul 17AIDS1126
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.Pence, Brian Wells ; Ostermann, Jan ; Kumar, Virender ; Whetten, Kathryn ; Thielman, Nathan ; Mugavero, Michael J2008 Feb 1J Acquir Immune Defic Syndr247
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionHaubrich, Richard H ; Riddler, Sharon A ; Ribaudo, Heather ; Direnzo, Gregory ; Klingman, Karin L ; Garren, Kevin W ; Butcher, David L ; Rooney, James F ; Havlir, Diane V ; Mellors, John W ; AIDS Clinical Trials Group (ACTG) A5160 and A5142 Study Teams2011 Nov 28AIDS1825
Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.Henrich, Timothy J ; Ribaudo, Heather J ; Kuritzkes, Daniel R2010 Jul 1Clin Infect Dis151
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.Keil, Kim ; Hochreitter, Jill ; DiFrancesco, Robin ; Zingman, Barry S ; Reichman, Richard C ; Fischl, Margaret A ; Gripshover, Barbara ; Morse, Gene D2007 FebTher Drug Monit129
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.Gulick, Roy M ; Lalama, Christina M ; Ribaudo, Heather J ; Shikuma, Cecilia M ; Schackman, Bruce R ; Schouten, Jeffrey ; Squires, Kathleen E ; Koletar, Susan L ; Pilcher, Christopher D ; Reichman, Richard C ; Klingman, Karin L ; Kuritzkes, Daniel R2007 Apr 23AIDS721
Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.Hu, Zixin ; Kuritzkes, Daniel R2011 NovJ Virol2185
Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.Petersen, Tess ; Lee, Yu-Jin ; Osinusi, Anu ; Amorosa, Valerianna K ; Wang, Crystal ; Kang, Minhee ; Matining, Roy ; Zhang, Xiao ; Dou, Diana ; Umbleja, Triin ; Kottilil, Shyam ; Peters, Marion G2016 JulAIDS Res Hum Retroviruses732
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.Manion, Maura ; Rodriguez, Benigno ; Medvik, Kathleen ; Hardy, Gareth ; Harding, Clifford V ; Schooley, Robert T ; Pollard, Richard ; Asmuth, David ; Murphy, Robert ; Barker, Edward ; Brady, Kirsten E ; Landay, Alan ; Funderburg, Nick ; Sieg, Scott F ; Lederman, Michael M2012PLoS One17
Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.Rodriguez, Benigno ; Lederman, Michael M ; Jiang, Wei ; Bazdar, Douglas A ; Gàrate, Kristen ; Harding, Clifford V ; Sieg, Scott F2006 Jun 26AIDS1020
Interleukin-7 promotes HIV persistence during antiretroviral therapy.Vandergeeten, Claire ; Fromentin, Rémi ; DaFonseca, Sandrina ; Lawani, Mariam B ; Sereti, Irini ; Lederman, Michael M ; Ramgopal, Moti ; Routy, Jean-Pierre ; Sekaly, Rafick-Pierre ; Chomont, Nicolas2013 May 23Blood21121
International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.Robertson, K ; Jiang, H ; Evans, S R ; Marra, C M ; Berzins, B ; Hakim, J ; Sacktor, N ; Silva, M Tulius ; Campbell, T B ; Nair, A ; Schouten, J ; 5271 study team ; Kumwenda, J ; Supparatpinyo, K ; Tripathy, S ; Kumarasamy, N ; La Rosa, A ; Montano, S ; Mwafongo, A ; Firnhaber, C ; Sanne, I ; Naini, L ; Amod, F ; Walawander, A ; AIDS Clini2016 AugJ Neurovirol422
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.Skiest, Daniel J ; Su, Zhaohui ; Havlir, Diane V ; Robertson, Kevin R ; Coombs, Robert W ; Cain, Pat ; Peterson, Tianna ; Krambrink, Amy ; Jahed, Nasreen ; McMahon, Deborah ; Margolis, David M ; AIDS Clinical Trials Group 5170 Study Team2007 May 15J Infect Dis10195
Intracellular Casp8p41 content is inversely associated with CD4 T cell count.Cummins, Nathan W ; Jiang, Wei ; McGinty, John ; Bren, Gary D ; Bosch, Ronald J ; Landay, Alan ; Deeks, Steven G ; Martin, Jeffrey N ; Douek, Daniel ; Lederman, Michael M ; Brenchley, Jason ; Badley, Andrew D2010 Aug 15J Infect Dis3202
Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.Moore, Jeff D ; Acosta, Edward P ; Johnson, Victoria A ; Bassett, Roland ; Eron, Joseph J ; Fischl, Margaret A ; Long, Mary C ; Kuritzkes, Daniel R ; Sommadossi, Jean-Pierre2007Antivir Ther612
ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection.Hochreiter, Jill ; Lapham, Jill ; Wong-Staal, Flossie ; McKelvy, Jeffrey ; Sulkowski, Mark ; Glesby, Marshall J ; Johnson, Victoria A ; Morse, Gene D2013Antivir Ther318
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.Parikh, Urvi M ; Bacheler, Lee ; Koontz, Dianna ; Mellors, John W2006 MayJ Virol1080
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.Smith, Davey M ; Strain, Matthew C ; Frost, Simon D W ; Pillai, Satish K ; Wong, Joseph K ; Wrin, Terri ; Liu, Yang ; Petropolous, Christos J ; Daar, Eric S ; Little, Susan J ; Richman, Douglas D2006 Nov 10Virology1355
Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study.Taiwo, Babafemi O ; Chan, Ellen S ; Fichtenbaum, Carl J ; Ribaudo, Heather ; Tsibris, Athe ; Klingman, Karin L ; Eron, Joseph J ; Berzins, Baiba ; Robertson, Kevin ; Landay, Alan ; Ofotokun, Igho ; Brown, Todd ; AIDS Clinical Trials Group A5303 Study Team2015 Oct 1Clin Infect Dis761
Leveraging prognostic baseline variables to gain precision in randomized trials.Colantuoni, Elizabeth ; Rosenblum, Michael2015 Aug 15Stat Med1834
Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.Livingston, Elizabeth G ; Cohn, Susan E ; Yang, Yang ; Watts, Heather D ; Bardeguez, Arlene D ; Jones, Theodore B ; Smith, Laura M ; Umbleja, Triin ; McComsey, Grace A2007 AugObstet Gynecol2 Pt 1110
Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Stein, James H ; Komarow, Lauren ; Cotter, Bruno R ; Currier, Judith S ; Dubé, Michael P ; Fichtenbaum, Carl J ; Gerschenson, Mariana ; Mitchell, Carol K C ; Murphy, Robert L ; Squires, Kathleen ; Parker, Robert A ; Torriani, Francesca J ; ACTG 5152s Study Team2008 DecJ Clin Lipidol62
Long-term body composition changes in antiretroviral-treated HIV-infected individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Bartali, Benedetta ; Koletar, Susan L ; Erlandson, Kristine M ; Lake, Jordan E ; Yin, Michael T ; Melbourne, Kathy ; Ha, Belinda ; Brown, Todd T2016 Nov 28AIDS1830
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.Dubé, Michael P ; Komarow, Lauren ; Mulligan, Kathleen ; Grinspoon, Steven K ; Parker, Robert A ; Robbins, Gregory K ; Roubenoff, Ronenn ; Tebas, Pablo ; Adult Clinical Trials Group 3842007 Aug 15J Acquir Immune Defic Syndr545
Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Collier, Ann C ; Koletar, Susan L ; Erlandson, Kristine M ; Yin, Michael T ; Bartali, Benedetta ; Ha, Belinda ; Melbourne, Kathy ; Brown, Todd T2016 Aug 15J Infect Dis4214
Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s).Clifford, David B ; Evans, Scott ; Yang, Yijun ; Acosta, Edward P ; Ribaudo, Heather ; Gulick, Roy M ; A5097s Study Team2009 Nov-DecHIV Clin Trials610
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection.Lok, Judith J ; Bosch, Ronald J ; Benson, Constance A ; Collier, Ann C ; Robbins, Gregory K ; Shafer, Robert W ; Hughes, Michael D ; ALLRT team2010 Jul 31AIDS1224
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.Bartlett, John A ; Ribaudo, Heather J ; Wallis, Carole L ; Aga, Evgenia ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Kallungal, Beatrice A ; Kumarasamy, Nagalingeswaran2012 Jul 17AIDS1126
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.Kumarasamy, Nagalingeswaran ; Aga, Evgenia ; Ribaudo, Heather J ; Wallis, Carole L ; Katzenstein, David A ; Stevens, Wendy S ; Norton, Michael R ; Klingman, Karin L ; Hosseinipour, Mina C ; Crump, John A ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Bartlett, John A2015 May 15Clin Infect Dis1060
Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.Boswell, Kristin L ; Paris, Robert ; Boritz, Eli ; Ambrozak, David ; Yamamoto, Takuya ; Darko, Sam ; Wloka, Kaska ; Wheatley, Adam ; Narpala, Sandeep ; McDermott, Adrian ; Roederer, Mario ; Haubrich, Richard ; Connors, Mark ; Ake, Julie ; Douek, Daniel C ; Kim, Jerome ; Petrovas, Constantinos ; Koup, Richard A2014 JanPLoS Pathog110
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.Grant, Philip M ; Kitch, Douglas ; McComsey, Grace A ; Dubé, Michael P ; Haubrich, Richard ; Huang, Jeannie ; Riddler, Sharon ; Tebas, Pablo ; Zolopa, Andrew R ; Collier, Ann C ; Brown, Todd T2013 NovClin Infect Dis1057
Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.Siddique, M Atif ; Hartman, Kelly E ; Dragileva, Ella ; Dondero, Marla ; Gebretsadik, Tebeb ; Shintani, Ayumi ; Peiperl, Laurence ; Valentine, Fred ; Kalams, Spyros A2006 Sep 1J Infect Dis5194
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.Halvas, Elias K ; Wiegand, Ann ; Boltz, Valerie F ; Kearney, Mary ; Nissley, Dwight ; Wantman, Michael ; Hammer, Scott M ; Palmer, Sarah ; Vaida, Florin ; Coffin, John M ; Mellors, John W2010 MarJ Infect Dis5201
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.Wohl, D A ; Kendall, M A ; Andersen, J ; Crumpacker, C ; Spector, S A ; Feinberg, J ; Alston-Smith, B ; Owens, S ; Chafey, S ; Marco, M ; Maxwell, S ; Lurain, N ; Jabs, D ; Benson, C ; Keiser, P ; Jacobson, M A ; A5030 Study Team2009 May-JunHIV Clin Trials310
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.Swindells, Susan ; Jiang, Hongyu ; Mukherjee, A Lisa ; Winters, Mark ; Bosch, Ronald J ; Katzenstein, David2011 Mar-AprHIV Clin Trials212
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals.Anthony, D D ; Umbleja, T ; Aberg, J A ; Kang, M ; Medvik, K ; Lederman, M M ; Peters, M G ; Koziel, M J ; Overton, E T2011 Apr 27Vaccine1929
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Svarovskaia, Evguenia S ; Metzner, Karin J ; Kozal, Michael J ; Hullsiek, Kathy Huppler ; Balduin, Melanie ; Jakobsen, Martin R ; Geretti, Anna Maria ; Thiebaut, Rodolphe ; Ostergaard, Lars ; Masquelier, Bernard ; Johnson, Jeffrey A ; Miller, Michael D ; Kuritzkes, Daniel R2011 Apr 6JAMA13305
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP.Boltz, Valerie F ; Bao, Yajing ; Lockman, Shahin ; Halvas, Elias K ; Kearney, Mary F ; McIntyre, James A ; Schooley, Robert T ; Hughes, Michael D ; Coffin, John M ; Mellors, John W ; OCTANE/A5208 Team2014 Mar 1J Infect Dis5209
The lymph node in HIV pathogenesis.Lederman, Michael M ; Margolis, Leonid2008 JunSemin Immunol320
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.Tsibris, Athe M N ; Paredes, Roger ; Chadburn, Amy ; Su, Zhaohui ; Henrich, Timothy J ; Krambrink, Amy ; Hughes, Michael D ; Aberg, Judith A ; Currier, Judith S ; Tashima, Karen ; Godfrey, Catherine ; Greaves, Wayne ; Flexner, Charles ; Skolnik, Paul R ; Wilkin, Timothy J ; Gulick, Roy M ; Kuritzkes, Daniel R2009 Mar 1Clin Infect Dis548
MACH14: a multi-site collaboration on ART adherence among 14 institutions.Liu, Honghu ; Wilson, Ira B ; Goggin, Kathy ; Reynolds, Nancy ; Simoni, Jane M ; Golin, Carol E ; Rosen, Marc I ; Gross, Robert ; Wagner, Glenn ; Remien, Robert H ; Schneiderman, Neil ; Erlen, Judith A ; Arnsten, Julia H ; Bangsberg, David R2013 JanAIDS Behav117
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1.Noviello, C M ; Pond, S L Kosakovsky ; Lewis, M J ; Richman, D D ; Pillai, S K ; Yang, O O ; Little, S J ; Smith, D M ; Guatelli, J C2007 MayJ Virol981
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.International HIV Controllers Study ; Pereyra, Florencia ; Jia, Xiaoming ; McLaren, Paul J ; DE Bakker, Paul I W ; Walker, Bruce D ; Ripke, Stephan ; Brumme, Chanson J ; Pulit, Sara L ; Carrington, Mary ; Kadie, Carl M ; Carlson, Jonathan M ; Heckerman, David ; Graham, Robert R ; Plenge, Robert M ; Deeks, Steven G ; Gianniny, Lauren ; Craw2010 Dec 10Science6010330
Markers of renal disease and function are associated with systemic inflammation in HIV infection.Gupta, S K ; Kitch, D ; Tierney, C ; Melbourne, K ; Ha, B ; McComsey, G A ; AIDS Clinical Trials Group Study A5224s Team2015 NovHIV Med1016
Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8(+) T cell immunity.Huang, Xiao-Li ; Fan, Zheng ; Borowski, Luann ; Rinaldo, Charles R2008 JunJ Leukoc Biol683
Measurement of antiretroviral drugs in the lungs of HIV-infected patients.Twigg, Homer L ; Schnizlein-Bick, Carol T ; Weiden, Michael ; Valentine, Fred ; Wheat, Joseph ; Day, Richard B ; Rominger, Helen ; Zheng, Lu ; Collman, Ronald G ; Coombs, Robert W ; Bucy, R Pat ; Rezk, Naser L ; Kashuba, Angela Dm2010 Mar 1HIV Ther24
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.Schacker, Timothy W ; Bosch, Ronald J ; Bennett, Kara ; Pollard, Richard ; Robbins, Gregory K ; Collier, Ann C ; Gulick, Roy M ; Spritzler, John ; Mildvan, Donna ; AIDS Clinical Trials Group2010 May 1J Acquir Immune Defic Syndr154
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.Schifitto, Giovanni ; Navia, Bradford A ; Yiannoutsos, Constantin T ; Marra, Christina M ; Chang, Linda ; Ernst, Thomas ; Jarvik, Jeffrey G ; Miller, Eric N ; Singer, Elyse J ; Ellis, Ronald J ; Kolson, Dennis L ; Simpson, David ; Nath, Avindra ; Berger, Joseph ; Shriver, Sharon L ; Millar, Linda L ; Colquhoun, Dodi ; Lenkinski, Robert ; G2007 Sep 12AIDS1421
Memantine for AIDS dementia complex: open-label report of ACTG 301.Zhao, Yu ; Navia, Bradford A ; Marra, Christina M ; Singer, Elyse J ; Chang, Linda ; Berger, Joseph ; Ellis, Ronald J ; Kolson, Dennis L ; Simpson, David ; Miller, Eric N ; Lipton, Stuart A ; Evans, Scott R ; Schifitto, Giovanni ; Adult Aids Clinical Trial Group (ACTG) 301 Team2010 Jan-FebHIV Clin Trials111
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy.Raboud, Janet M ; Diong, Christina ; Carr, Andrew ; Grinspoon, Steven ; Mulligan, Kathleen ; Sutinen, Jussi ; Rozenbaum, William ; Cavalcanti, Rodrigo B ; Wand, Handan ; Costagliola, Dominique ; Walmsley, Sharon ; Glitazone and Lipoatrophy Meta-Analysis Working Group2010 Jan-FebHIV Clin Trials111
Meta-analysis of the safety, tolerability, and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in HIV-1-infected women.Hermes, A ; Squires, K ; Fredrick, L ; Martinez, M ; Pasley, M ; Trinh, R ; Norton, M2012 Nov-DecHIV Clin Trials613
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.Tebas, Pablo ; Henry, William Keith ; Matining, Roy ; Weng-Cherng, Deborah ; Schmitz, John ; Valdez, Hernan ; Jahed, Nasreen ; Myers, Laurie ; Powderly, William G ; Katzenstein, David2008PLoS One43
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).Shikuma, Cecilia M ; Yang, Yang ; Glesby, Marshall J ; Meyer, William A ; Tashima, Karen T ; Ribaudo, Heather J ; Webb, Nancy ; Bastow, Barbara ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Apr 15J Acquir Immune Defic Syndr544
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals.Krishnan, Supriya ; Schouten, Jeffrey T ; Atkinson, Benjamin ; Brown, Todd ; Wohl, David ; McComsey, Grace A ; Glesby, Marshall J ; Shikuma, Cecilia ; Haubrich, Richard ; Tebas, Pablo ; Campbell, Thomas B ; Jacobson, Denise L2012 Nov 1J Acquir Immune Defic Syndr361
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.Brenchley, Jason M ; Price, David A ; Schacker, Timothy W ; Asher, Tedi E ; Silvestri, Guido ; Rao, Srinivas ; Kazzaz, Zachary ; Bornstein, Ethan ; Lambotte, Olivier ; Altmann, Daniel ; Blazar, Bruce R ; Rodriguez, Benigno ; Teixeira-Johnson, Leia ; Landay, Alan ; Martin, Jeffrey N ; Hecht, Frederick M ; Picker, Louis J ; Lederman, Michael2006 DecNat Med1212
Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.Sacktor, N ; Miyahara, S ; Deng, L ; Evans, S ; Schifitto, G ; Cohen, B A ; Paul, R ; Robertson, K ; Jarocki, B ; Scarsi, K ; Coombs, R W ; Zink, M C ; Nath, A ; Smith, E ; Ellis, R J ; Singer, E ; Weihe, J ; McCarthy, S ; Hosey, L ; Clifford, D B ; ACTG A5235 team2011 Sep 20Neurology1277
Minorities remain underrepresented in HIV/AIDS research despite access to clinical trials.Castillo-Mancilla, Jose R ; Cohn, Susan E ; Krishnan, Supriya ; Cespedes, Michelle ; Floris-Moore, Michelle ; Schulte, Gail ; Pavlov, Gregory ; Mildvan, Donna ; Smith, Kimberly Y2014 Jan-FebHIV Clin Trials115
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South.Pence, Brian Wells ; Reif, Susan ; Whetten, Kathryn ; Leserman, Jane ; Stangl, Dalene ; Swartz, Marvin ; Thielman, Nathan ; Mugavero, Michael J2007 NovSouth Med J11100
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.Abraham, Alison G ; Lau, Bryan ; Deeks, Steven ; Moore, Richard D ; Zhang, Jinbing ; Eron, Joseph ; Harrigan, Richard ; Gill, M John ; Kitahata, Mari ; Klein, Marina ; Napravnik, Sonia ; Rachlis, Anita ; Rodriguez, Benigno ; Rourke, Sean ; Benson, Constance ; Bosch, Ron ; Collier, Ann ; Gebo, Kelly ; Goedert, James ; Hogg, Robert ; Horberg2011 Sep 15Am J Epidemiol6174
Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.Hulgan, Todd ; Stein, James H ; Cotter, Bruno R ; Murdock, Deborah G ; Ritchie, Marylyn D ; Dubé, Michael P ; Gerschenson, Mariana ; Haas, David W ; Torriani, Francesca J ; Aids Clinical Trials Group A5152s And Dacs 252 Study Teams2013 OctAIDS Res Hum Retroviruses1029
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.Grady, Benjamin J ; Samuels, David C ; Robbins, Gregory K ; Selph, Doug ; Canter, Jeffrey A ; Pollard, Richard B ; Haas, David W ; Shafer, Robert ; Kalams, Spyros A ; Murdock, Deborah G ; Ritchie, Marylyn D ; Hulgan, Todd ; ACTG 384 and DACS 250 Study Teams2011 Dec 1J Acquir Immune Defic Syndr458
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.Canter, J A ; Haas, D W ; Kallianpur, A R ; Ritchie, M D ; Robbins, G K ; Shafer, R W ; Clifford, D B ; Murdock, D G ; Hulgan, T2008 FebPharmacogenomics J18
Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial.Mulligan, Kathleen ; Parker, Robert A ; Komarow, Lauren ; Grinspoon, Steven K ; Tebas, Pablo ; Robbins, Gregory K ; Roubenoff, Ronenn ; Dubé, Michael P2006 Apr 15J Acquir Immune Defic Syndr541
Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis.Svensson, Elin M ; Aweeka, Francesca ; Park, Jeong-Gun ; Marzan, Florence ; Dooley, Kelly E ; Karlsson, Mats O2013 JunAntimicrob Agents Chemother657
Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times.Johnson, Brent A ; Ribaudo, Heather ; Gulick, Roy M ; Eron, Joseph J2013 SepBiometrics369
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Gross, Robert ; Tierney, Camlin ; Andrade, Adriana ; Lalama, Christina ; Rosenkranz, Susan ; Eshleman, Susan H ; Flanigan, Timothy ; Santana, Jorge ; Salomon, Nadim ; Reisler, Ronald ; Wiggins, Ilene ; Hogg, Evelyn ; Flexner, Charles ; Mildvan, Donna ; AIDS Clinical Trials Group A5073 Study Team2009 Jul 13Arch Intern Med13169
Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.Lederman, Michael M ; Penn-Nicholson, Adam ; Stone, Shelley F ; Sieg, Scott F ; Rodriguez, Benigno2007 JanCurr Opin HIV AIDS12
More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175.Shulman, Nancy S ; Kassaye, Seble G ; Winters, Mark A ; Johnston, Elizabeth ; Katzenstein, David A2007 Jul 15J Infect Dis2196
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.Schifitto, G ; Zhang, J ; Evans, S R ; Sacktor, N ; Simpson, D ; Millar, L L ; Hung, V L ; Miller, E N ; Smith, E ; Ellis, R J ; Valcour, V ; Singer, E ; Marra, C M ; Kolson, D ; Weihe, J ; Remmel, R ; Katzenstein, D ; Clifford, D B ; ACTG A5090 Team2007 Sep 25Neurology1369
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.Critchfield, J William ; Lemongello, Donna ; Walker, Digna H ; Garcia, Juan C ; Asmuth, David M ; Pollard, Richard B ; Shacklett, Barbara L2007 JunJ Virol1181
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.Motsinger, Alison A ; Ritchie, Marylyn D ; Shafer, Robert W ; Robbins, Gregory K ; Morse, Gene D ; Labbe, Line ; Wilkinson, Grant R ; Clifford, David B ; D'Aquila, Richard T ; Johnson, Victoria A ; Pollard, Richard B ; Merigan, Thomas C ; Hirsch, Martin S ; Donahue, John P ; Kim, Richard B ; Haas, David W2006 NovPharmacogenet Genomics1116
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.Robertson, Kevin ; Kumwenda, Johnstone ; Supparatpinyo, Khuanchai ; Jiang, Jeanne H ; Evans, Scott ; Campbell, Thomas B ; Price, Richard W ; Murphy, Robert ; Hall, Colin ; Marra, Christina M ; Marcus, Cheryl ; Berzins, Baiba ; Masih, Reena ; Santos, Breno ; Silva, Marcus T ; Kumarasamy, N ; Walawander, Ann ; Nair, Apsara ; Tripathy, Srikan2011 OctJ Neurovirol517
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.Stone, Nimalie D ; Dunaway, Shelia B ; Flexner, Charles ; Tierney, Camlin ; Calandra, Gary B ; Becker, Stephen ; Cao, Ying-Jun ; Wiggins, Ilene P ; Conley, Jeanne ; MacFarland, Ron T ; Park, Jeong-Gun ; Lalama, Christina ; Snyder, Sally ; Kallungal, Beatrice ; Klingman, Karin L ; Hendrix, Craig W2007 JulAntimicrob Agents Chemother751
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.Mitsuya, Yumi ; Winters, Mark A ; Fessel, W Jeffrey ; Rhee, Soo-Yon ; Hurley, Leo ; Horberg, Michael ; Schiffer, Celia A ; Zolopa, Andrew R ; Shafer, Robert W2006 DecAIDS Res Hum Retroviruses1222
Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.Robertson, Kevin R ; Miyahara, Sachiko ; Lee, Anthony ; Brown, Todd T ; Chan, Ellen S ; Berzins, Baiba ; Rusin, David ; Eron, Joseph J ; Taiwo, Babafemi O ; ACTG 5303 team2016 Jun 20AIDS
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.Robertson, K R ; Su, Z ; Margolis, D M ; Krambrink, A ; Havlir, D V ; Evans, S ; Skiest, D J ; A5170 Study Team2010 Apr 20Neurology1674
Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.Parsons, Thomas D ; Tucker, Karen A ; Hall, Colin D ; Robertson, Wendy T ; Eron, Joseph J ; Fried, Michael W ; Robertson, Kevin R2006 Aug 1AIDS1220
Neuropsychiatric complications of antiretroviral therapy.Cespedes, Michelle S ; Aberg, Judith A2006Drug Saf1029
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.Dong, Betty J ; Zheng, Yu ; Hughes, Michael D ; Frymoyer, Adam ; Verotta, Davide ; Lizak, Patricia ; Sawe, Frederick ; Currier, Judith S ; Lockman, Shahin ; Aweeka, Francesca T ; AIDS Clinical Trials Group Study 5208 Team2012 Apr 24AIDS726
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.Lockman, Shahin ; Hughes, Michael ; Sawe, Fred ; Zheng, Yu ; McIntyre, James ; Chipato, Tsungai ; Asmelash, Aida ; Rassool, Mohammed ; Kimaiyo, Sylvester ; Shaffer, Douglas ; Hosseinipour, Mina ; Mohapi, Lerato ; Ssali, Francis ; Chibowa, Margret ; Amod, Farida ; Halvas, Elias ; Hogg, Evelyn ; Alston-Smith, Beverly ; Smith, Laura ; Schoole2012PLoS Med69
A new approach for 'deep salvage' trials in advanced HIV infection.Lederman, Michael M ; Miller, Veronica ; Weller, Ian ; Deeks, Steven G2007 Jul 31AIDS1221
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.McLaughlin, Bridget E ; Baumgarth, Nicole ; Bigos, Martin ; Roederer, Mario ; De Rosa, Stephen C ; Altman, John D ; Nixon, Douglas F ; Ottinger, Janet ; Oxford, Carol ; Evans, Thomas G ; Asmuth, David M2008 MayCytometry A573
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.McLaughlin, Bridget E ; Baumgarth, Nicole ; Bigos, Martin ; Roederer, Mario ; De Rosa, Stephen C ; Altman, John D ; Nixon, Douglas F ; Ottinger, Janet ; Li, Judy ; Beckett, Laurel ; Shacklett, Barbara L ; Evans, Thomas G ; Asmuth, David M2008 MayCytometry A573
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.Gandhi, Rajesh T ; Coombs, Robert W ; Chan, Ellen S ; Bosch, Ronald J ; Zheng, Lu ; Margolis, David M ; Read, Sarah ; Kallungal, Beatrice ; Chang, Ming ; Goecker, Erin A ; Wiegand, Ann ; Kearney, Mary ; Jacobson, Jeffrey M ; D'Aquila, Richard ; Lederman, Michael M ; Mellors, John W ; Eron, Joseph J ; AIDS Clinical Trials Group (ACTG) A52442012 Mar 1J Acquir Immune Defic Syndr359
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.Gandhi, Rajesh T ; Bosch, Ronald J ; Aga, Evgenia ; Albrecht, Mary ; Demeter, Lisa M ; Dykes, Carrie ; Bastow, Barbara ; Para, Michael ; Lai, Jun ; Siliciano, Robert F ; Siliciano, Janet D ; Eron, Joseph J ; AIDS Clinical Trials Group A5173 Team2010 Jan 15J Infect Dis2201
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.Ribaudo, Heather J ; Benson, Constance A ; Zheng, Yu ; Koletar, Susan L ; Collier, Ann C ; Lok, Judith J ; Smurzynski, Marlene ; Bosch, Ronald J ; Bastow, Barbara ; Schouten, Jeffrey T ; ACTG A5001/ALLRT Protocol Team2011 Apr 1Clin Infect Dis752
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359.Haubrich, Richard H ; Jiang, Hongyu ; Swanstrom, Ronald ; Bates, Michael ; Katzenstein, David ; Petch, Leslie ; Fletcher, Courtney V ; Fiscus, Susan A ; Gulick, Roy M ; AIDS Clinical Trials Group Protocol 359 Team2007 Mar-AprHIV Clin Trials28
Nonparametric estimation of the mean function of a stochastic process with missing observations.Hu, X Joan ; Lagakos, Stephen W2007 MarLifetime Data Anal113
Nonparametric tests for two-group comparisons of dependent observations obtained at varying time points.May, Susanne ; Degruttola, Victor2007 MarBiometrics163
A novel codon insert in protease of clade B HIV type 1.Jordan, Parris S ; Poon, Art ; Eron, Joseph ; Squires, Kathleen ; Ignacio, Caroline ; Richman, Douglas D ; Smith, Davey M2009 MayAIDS Res Hum Retroviruses525
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.Dooley, Kelly E ; Savic, Radojka M ; Park, Jeong-Gun ; Cramer, Yoninah ; Hafner, Richard ; Hogg, Evelyn ; Janik, Jennifer ; Marzinke, Mark A ; Patterson, Kristine ; Benson, Constance A ; Hovind, Laura ; Dorman, Susan E ; Haas, David W ; ACTG A5311 Study Team2015Antimicrob Agents Chemother659
Older age is associated with peripheral blood expansion of naïve B cells in HIV-infected subjects on antiretroviral therapy.Van Epps, Puja ; Matining, Roy M ; Tassiopoulos, Katherine ; Anthony, Donald D ; Landay, Alan ; Kalayjian, Robert C ; Canaday, David H2014PLoS One99
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.Kalayjian, Robert C ; Spritzler, John ; Matining, Roy M ; Fiscus, Susan A ; Gross, Barry H ; Francis, Isaac R ; Pollard, Richard B ; Lederman, Michael M ; Landay, Alan2013 Jun 19AIDS1027
Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis.Reynolds, Nancy R ; Sun, Junfeng ; Nagaraja, Haikady N ; Gifford, Allen L ; Wu, Albert W ; Chesney, Margaret A2007 Dec 1J Acquir Immune Defic Syndr446
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.Hulgan, Todd ; Donahue, John P ; Smeaton, Laura ; Pu, Minya ; Wang, Hongying ; Lederman, Michael M ; Smith, Kimberly ; Valdez, Hernan ; Pilcher, Christopher ; Haas, David W ; AIDS Clinical Trials Group Study A5138 Team2009 NovEur J Clin Pharmacol1165
Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.Kearney, Mary F ; Wiegand, Ann ; Shao, Wei ; Coffin, John M ; Mellors, John W ; Lederman, Michael ; Gandhi, Rajesh T ; Keele, Brandon F ; Li, Jonathan Z2016 FebJ Virol390
Osteopenia and osteoporosis in patients with HIV: a review of current concepts.Brown, Todd T ; McComsey, Grace A2006 MarCurr Infect Dis Rep28
Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease.Périssé, André R S ; Smeaton, Laura ; Chen, Yun ; La Rosa, Alberto ; Walawander, Ann ; Nair, Apsara ; Grinsztejn, Beatriz ; Santos, Breno ; Kanyama, Cecilia ; Hakim, James ; Nyirenda, Mulinda ; Kumarasamy, Nagalingeswaran ; Lalloo, Umesh G ; Flanigan, Timothy ; Campbell, Thomas B ; Hughes, Michael D ; P E A R L S study team of the ACTG2013PLoS One128
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.Smith, Kimberly Y ; Tierney, Camlin ; Mollan, Katie ; Venuto, Charles S ; Budhathoki, Chakra ; Ma, Qing ; Morse, Gene D ; Sax, Paul ; Katzenstein, David ; Godfrey, Catherine ; Fischl, Margaret ; Daar, Eric S ; Collier, Ann C ; AIDS Clinical Trials Group 5202 Study Team2014 FebClin Infect Dis458
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.Hulgan, Todd ; Hughes, Michael ; Sun, Xin ; Smeaton, Laura M ; Terry, Erin ; Robbins, Gregory K ; Shafer, Robert W ; Clifford, David B ; McComsey, Grace A ; Canter, Jeffery A ; Morrow, Jason D ; Haas, David W2006 Aug 1J Acquir Immune Defic Syndr442
Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).Gross, Robert ; Zheng, Lu ; La Rosa, Alberto ; Sun, Xin ; Rosenkranz, Susan L ; Cardoso, Sandra Wagner ; Ssali, Francis ; Camp, Rob ; Godfrey, Catherine ; Cohn, Susan E ; Robbins, Gregory K ; Chisada, Anthony ; Wallis, Carole L ; Reynolds, Nancy R ; Lu, Darlene ; Safren, Steven A ; Hosey, Lara ; Severe, Patrice ; Collier, Ann C2015 Jan 1Lancet HIV12
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.Genberg, Becky L ; Wilson, Ira B ; Bangsberg, David R ; Arnsten, Julia ; Goggin, Kathy ; Remien, Robert H ; Simoni, Jane ; Gross, Robert ; Reynolds, Nancy ; Rosen, Marc ; Liu, Honghu ; MACH14 Investigators2012 Jul 17AIDS1126
Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.Lee, Anthony J ; Bosch, Ronald J ; Evans, Scott R ; Wu, Kunling ; Harrison, Taylor ; Grant, Philip ; Clifford, David B2015 AprJ Neurovirol221
Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.Stewart, Paul ; Cachafeiro, Ada ; Napravnik, Sonia ; Eron, Joseph J ; Frank, Ian ; van der Horst, Charles ; Bosch, Ronald J ; Bettendorf, Daniel ; Bohlin, Peter ; Fiscus, Susan A2010 NovJ Clin Virol349
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tebas, Pablo ; Tierney, Camlin ; Jahed, Nasreen C ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Daar, Eric S2011 Jul 15Clin Infect Dis253
Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.Tebas, P ; Zhang, J ; Hafner, R ; Tashima, K ; Shevitz, A ; Yarasheski, K ; Berzins, B ; Owens, S ; Forand, J ; Evans, S ; Murphy, R2009 MayJ Antimicrob Chemother563
Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.Chen, Huichao ; Clifford, David B ; Deng, Lijuan ; Wu, Kunling ; Lee, Anthony J ; Bosch, Ronald J ; Riddler, Sharon A ; Ellis, Ronald J ; Evans, Scott R2013 DecJ Neurovirol619
Peripheral neuropathy in HIV: prevalence and risk factors.Evans, Scott R ; Ellis, Ronald J ; Chen, Huichao ; Yeh, Tzu-min ; Lee, Anthony J ; Schifitto, Giovanni ; Wu, Kunling ; Bosch, Ronald J ; McArthur, Justin C ; Simpson, David M ; Clifford, David B2011 Apr 24AIDS725
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.Palmer, S ; Boltz, V ; Martinson, N ; Maldarelli, F ; Gray, G ; McIntyre, J ; Mellors, J ; Morris, L ; Coffin, J2006 May 2Proc Natl Acad Sci U S A18103
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.Shivakoti, Rupak ; Yang, Wei-Teng ; Berendes, Sima ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Balagopal, Ashwin ; Gupte, Nikhil ; Semba, Richard D ; Campbell2016 Apr 1J Infect Dis7213
Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.Kelesidis, Theodoros ; Kendall, Michelle A ; Yang, Otto O ; Hodis, Howard ; Currier, Judith S2013 JunAIDS Res Hum Retroviruses629
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.Wu, Hulin ; Huang, Yangxin ; Acosta, Edward P ; Park, Jeong-Gun ; Yu, Song ; Rosenkranz, Susan L ; Kuritzkes, Daniel R ; Eron, Joseph J ; Perelson, Alan S ; Gerber, John G2006 AugJ Pharmacokinet Pharmacodyn433
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Haas, David W ; Bartlett, John A ; Andersen, Janet W ; Sanne, Ian ; Wilkinson, Grant R ; Hinkle, John ; Rousseau, Franck ; Ingram, Christiana D ; Shaw, Audrey ; Lederman, Michael M ; Kim, Richard B ; Adult AIDS Clinical Trials Group2006 Sep 15Clin Infect Dis643
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Ribaudo, Heather J ; Haas, David W ; Tierney, Camlin ; Kim, Richard B ; Wilkinson, Grant R ; Gulick, Roy M ; Clifford, David B ; Marzolini, Catia ; Fletcher, Courtney V ; Tashima, Karen T ; Kuritzkes, Daniel R ; Acosta, Edward P ; Adult AIDS Clinical Trials Group Study2006 Feb 1Clin Infect Dis342
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).Castillo-Mancilla, Jose R ; Aquilante, Christina L ; Wempe, Michael F ; Smeaton, Laura M ; Firnhaber, Cynthia ; LaRosa, Alberto M ; Kumarasamy, Nagalingeswaran ; Andrade, Adriana ; Baheti, Gautam ; Fletcher, Courtney V ; Campbell, Thomas B ; Haas, David W ; MaWhinney, Samantha ; Anderson, Peter L2016 JunJ Antimicrob Chemother671
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.Aweeka, F T ; Kang, M ; Yu, J-Y ; Lizak, P ; Alston, B ; Chung, R T ; AIDS Clinical Trials Group 5092s Study Team2007 JulHIV Med58
PHARMACOKINETIC EXPOSURE AND VIROLOGIC RESPONSE IN HIV-1 INFECTED PREGNANT WOMEN TREATED WITH LOPINAVIR/RITONAVIR: AIDS CLINICAL TRIALS GROUP PROTOCOL A5153S: A SUBSTUDY TO A5150.Sha, Beverly E ; Tierney, Camlin ; Sun, Xin ; Stek, Alice ; Cohn, Susan E ; Coombs, Robert W ; Bastow, Barbara ; Aweeka, Francesca T ; AIDS Clinical Trials Group (ACTG) 5153s Team2015Jacobs J AIDS HIV11
Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers.Ma, Qing ; Forrest, Alan ; Rosenkranz, Susan L ; Para, Michael F ; Yarasheski, Kevin E ; Reichman, Richard C ; Morse, Gene D ; ACTG A5043 Protocol Team, DAIDS, NIH2008 MarBiopharm Drug Dispos229
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.Aberg, Judith A ; Rosenkranz, Susan L ; Fichtenbaum, Carl J ; Alston, Beverly L ; Brobst, Susan W ; Segal, Yoninah ; Gerber, John G ; ACTG A5108 team2006 Mar 21AIDS520
Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211).Crawford, Keith W ; Li, Chonghua ; Keung, Anther ; Su, Zhaohui ; Hughes, Michael D ; Greaves, Wayne ; Kuritzkes, Daniel ; Gulick, Roy ; Flexner, Charles ; ACTG A5211 Study Team2010 AprJ Acquir Immune Defic Syndr553
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.Gupta, Samir K ; Rosenkranz, Susan L ; Cramer, Yoninah S ; Koletar, Susan L ; Szczech, Lynda A ; Amorosa, Valerianna ; Hall, Stephen D2008 Oct 1AIDS1522
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.Gulick, Roy M ; Su, Zhaohui ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Wilkin, Timothy J ; Gross, Robert ; Krambrink, Amy ; Coakley, Eoin ; Greaves, Wayne L ; Zolopa, Andrew ; Reichman, Richard ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group 5211 Team2007 Jul 15J Infect Dis2196
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.Dooley, Kelly E ; Luetkemeyer, Anne F ; Park, Jeong-Gun ; Allen, Reena ; Cramer, Yoninah ; Murray, Stephen ; Sutherland, Deborah ; Aweeka, Francesca ; Koletar, Susan L ; Marzan, Florence ; Bao, Jing ; Savic, Rada ; Haas, David W ; AIDS Clinical Trials Group A5306 Study Team2014 SepAntimicrob Agents Chemother958
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.Para, Michael F ; Schouten, Jeff ; Rosenkranz, Susan L ; Yu, Song ; Weiner, David ; Tebas, Pablo ; White, C Jo ; Reeds, Dominic ; Lertora, Juan ; Patterson, Kristine B ; Daar, Eric S ; Cavert, Winston ; Brizz, Barbara ; ACTG A5200 Team of the ACTG2010 Apr 1J Acquir Immune Defic Syndr453
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols.Moore, Carrie B ; Verma, Anurag ; Pendergrass, Sarah ; Verma, Shefali S ; Johnson, Daniel H ; Daar, Eric S ; Gulick, Roy M ; Haubrich, Richard ; Robbins, Gregory K ; Ritchie, Marylyn D ; Haas, David W2015 JanOpen Forum Infect Dis12
PHENOME-WIDE INTERACTION STUDY (PheWIS) IN AIDS CLINICAL TRIALS GROUP DATA (ACTG).Verma, Shefali S ; Frase, Alex T ; Verma, Anurag ; Pendergrass, Sarah A ; Mahony, Shaun ; Haas, David W ; Ritchie, Marylyn D2016Pac Symp Biocomput21
Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.Derache, Anne ; Wallis, Carole L ; Vardhanabhuti, Saran ; Bartlett, John ; Kumarasamy, Nagalingeswaran ; Katzenstein, David2016 Jan 15J Infect Dis2213
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.Vardhanabhuti, Saran ; Taiwo, Babafemi ; Kuritzkes, Daniel R ; Eron, Joseph J ; Bosch, Ronald J2015Antivir Ther120
Physicians' attitudes toward homosexuality and HIV: survey of a California Medical Society- revisited (PATHH-II).Smith, Davey M ; Mathews, Wm Christopher2007J Homosex3-452
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.Henry, Keith ; Katzenstein, David ; Cherng, Deborah Weng ; Valdez, Hernan ; Powderly, William ; Vargas, Michelle Blanchard ; Jahed, Nasreen C ; Jacobson, Jeffrey M ; Myers, Laurie S ; Schmitz, John L ; Winters, Mark ; Tebas, Pablo ; A5102 Study Team of the AIDS Clinical Trials Group2006 JunJ Acquir Immune Defic Syndr242
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Marks, Kristen M ; Kitch, Douglas ; Chung, Raymond T ; Hadigan, Colleen ; Andersen, Janet ; Tien, Phyllis ; Luetkemeyer, Annie ; Alston-Smith, Beverly ; Glesby, Marshall J ; A5239 Team2014 Mar 1J Acquir Immune Defic Syndr365
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.Tungsiripat, Marisa ; Kitch, Douglas ; Glesby, Marshall J ; Gupta, Samir K ; Mellors, John W ; Moran, Laura ; Jones, Lynne ; Alston-Smith, Beverly ; Rooney, James F ; Aberg, Judith A2010 Jul 17AIDS1124
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.Wilkin, Timothy J ; Lalama, Christina M ; McKinnon, John ; Gandhi, Rajesh T ; Lin, Nina ; Landay, Alan ; Ribaudo, Heather ; Fox, Lawrence ; Currier, Judith S ; Mellors, John W ; Gulick, Roy ; Tenorio, Allan R2012 Aug 15J Infect Dis4206
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.Schifitto, Giovanni ; Yiannoutsos, Constantin T ; Simpson, David M ; Marra, Christina M ; Singer, Elyse J ; Kolson, Dennis L ; Nath, Avindra ; Berger, Joseph R ; Navia, Bradford ; Adult AIDS Clinical Trials Group (ACTG) 301 tEAM2006 AugJ Neurovirol412
Plasma apolipoprotein L1 levels do not correlate with CKD.Bruggeman, Leslie A ; O'Toole, John F ; Ross, Michael D ; Madhavan, Sethu M ; Smurzynski, Marlene ; Wu, Kunling ; Bosch, Ronald J ; Gupta, Samir ; Pollak, Martin R ; Sedor, John R ; Kalayjian, Robert C2014 MarJ Am Soc Nephrol325
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.Kuritzkes, Daniel R ; Ribaudo, Heather J ; Squires, Kathleen E ; Koletar, Susan L ; Santana, Jorge ; Riddler, Sharon A ; Reichman, Richard ; Shikuma, Cecilia ; Meyer, William A ; Klingman, Karin L ; Gulick, Roy M ; ACTG A5166s Protocol Team2007 Apr 15J Infect Dis8195
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.Jiang, Wei ; Lederman, Michael M ; Hunt, Peter ; Sieg, Scott F ; Haley, Kathryn ; Rodriguez, Benigno ; Landay, Alan ; Martin, Jeffrey ; Sinclair, Elizabeth ; Asher, Ava I ; Deeks, Steven G ; Douek, Daniel C ; Brenchley, Jason M2009 Apr 15J Infect Dis8199
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs.Hennig, Stefanie ; Svensson, Elin M ; Niebecker, Ronald ; Fourie, P Bernard ; Weiner, Marc H ; Bonora, Stefano ; Peloquin, Charles A ; Gallicano, Keith ; Flexner, Charles ; Pym, Alex ; Vis, Peter ; Olliaro, Piero L ; McIlleron, Helen ; Karlsson, Mats O2016 MayJ Antimicrob Chemother571
Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.Sha, Beverly E ; Tierney, Camlin ; Cohn, Susan E ; Sun, Xin ; Coombs, Robert W ; Frenkel, Lisa M ; Kalams, Spyros A ; Aweeka, Francesca T ; Bastow, Barbara ; Bardeguez, Arlene ; Kmack, Anne ; Stek, Alice ; Aids Clinical Trials Group ACTG A5150 Team2011 Jan-FebHIV Clin Trials112
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.Abbas, Ume L ; Anderson, Roy M ; Mellors, John W2006 Apr 15J Acquir Immune Defic Syndr541
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.Schackman, Bruce R ; Scott, Callie A ; Sax, Paul E ; Losina, Elena ; Wilkin, Timothy J ; McKinnon, John E ; Swindells, Susan ; Weinstein, Milton C ; Freedberg, Kenneth A2007 Oct 15Clin Infect Dis845
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.Shivakoti, Rupak ; Gupte, Nikhil ; Yang, Wei-Teng ; Mwelase, Noluthando ; Kanyama, Cecilia ; Tang, Alice M ; Pillay, Sandy ; Samaneka, Wadzanai ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Semba, Richard D ; Christian, Parul ; Campbell, Thomas B ; Gupta, Amita ; NWCS 319 and PEARLS2014 NovNutrients116
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study.Balagopal, Ashwin ; Asmuth, David M ; Yang, Wei-Teng ; Campbell, Thomas B ; Gupte, Nikhil ; Smeaton, Laura ; Kanyama, Cecilia ; Grinsztejn, Beatriz ; Santos, Breno ; Supparatpinyo, Khuanchai ; Badal-Faesen, Sharlaa ; Lama, Javier R ; Lalloo, Umesh G ; Zulu, Fatima ; Pawar, Jyoti S ; Riviere, Cynthia ; Kumarasamy, Nagalingeswaran ; Hakim, J2015 Oct 1J Acquir Immune Defic Syndr270
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm.Rutstein, Sarah E ; Hosseinipour, Mina C ; Weinberger, Morris ; Wheeler, Stephanie B ; Biddle, Andrea K ; Wallis, Carole L ; Balakrishnan, Pachamuthu ; Mellors, John W ; Morgado, Mariza ; Saravanan, Shanmugam ; Tripathy, Srikanth ; Vardhanabhuti, Saran ; Eron, Joseph J ; Miller, William C2016BMC Infect Dis116
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.Eron, Joseph J ; Park, Jeong-Gun ; Haubrich, Richard ; Aweeka, Francesca ; Bastow, Barbara ; Pakes, Gary E ; Yu, Song ; Wu, Hulin ; Richman, Douglas D ; ACTG5126 Study Team2009 JunAntimicrob Agents Chemother653
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study.Crump, John A ; Wu, Xingye ; Kendall, Michelle A ; Ive, Prudence D ; Kumwenda, Johnstone J ; Grinsztejn, Beatriz ; Jentsch, Ute ; Swindells, Susan2015BMC Infect Dis15
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort.Mugavero, Michael J ; Pence, Brian Wells ; Whetten, Kathryn ; Leserman, Jane ; Swartz, Marvin ; Stangl, Dalene ; Thielman, Nathan M2007 SepAIDS Patient Care STDS921
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).Servoss, Julie C ; Kitch, Douglas W ; Andersen, Janet W ; Reisler, Ronald B ; Chung, Raymond T ; Robbins, Gregory K2006 Nov 1J Acquir Immune Defic Syndr343
Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy.Singini, Isaac ; Campbell, Thomas B ; Smeaton, Laura M ; Kumarasamy, Nagalingeswaran ; La Rosa, Alberto ; Taejareonkul, Sineenart ; Safren, Steven A ; Flanigan, Timothy P ; Hakim, James G ; Hughes, Michael D ; ACTG A5175/PEARLS Study Team.2016 Jul 29HIV Clin Trials
Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapy.Zheng, Lu ; Bosch, Ronald J ; Chan, Ellen S ; Read, Sarah ; Kearney, Mary ; Margolis, David M ; Mellors, John W ; Eron, Joseph J ; Gandhi, Rajesh T ; DS Clinical Trials Group (ACTG) A5244 Team2013Antivir Ther118
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Asmelash, Aida ; Zheng, Yu ; Kaloustian, Kara Wools ; Shaffer, Douglas ; Sawe, Fred ; Ogwu, Anthony ; Salata, Robert ; Currier, Judith ; Hughes, Michael D ; Lockman, Shahin2014BMC Infect Dis14
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.Paredes, Roger ; Lalama, Christina M ; Ribaudo, Heather J ; Schackman, Bruce R ; Shikuma, Cecilia ; Giguel, Francoise ; Meyer, William A ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Gulick, Roy M ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group (ACTG) A5095 Study Team2010 MarJ Infect Dis5201
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.Kuritzkes, Daniel R ; Lalama, Christina M ; Ribaudo, Heather J ; Marcial, Michelle ; Meyer, William A ; Shikuma, Cecilia ; Johnson, Victoria A ; Fiscus, Susan A ; D'Aquila, Richard T ; Schackman, Bruce R ; Acosta, Edward P ; Gulick, Roy M2008 Mar 15J Infect Dis6197
Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population.Orlov, Marika ; Smeaton, Laura M ; Kumwenda, Johnstone ; Hosseinipour, Mina C ; Campbell, Thomas B ; Schooley, Robert T2015PLoS One610
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.Bosch, Ronald J ; Bennett, Kara ; Collier, Ann C ; Zackin, Robert ; Benson, Constance A2007 Mar 1J Acquir Immune Defic Syndr344
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Kantor, Rami ; Smeaton, Laura ; Vardhanabhuti, Saran ; Hudelson, Sarah E ; Wallis, Carol L ; Tripathy, Srikanth ; Morgado, Mariza G ; Saravanan, Shanmugham ; Balakrishnan, Pachamuthu ; Reitsma, Marissa ; Hart, Stephen ; Mellors, John W ; Halvas, Elias ; Grinsztejn, Beatriz ; Hosseinipour, Mina C ; Kumwenda, Johnstone ; La Rosa, Alberto ; L2015 May 15Clin Infect Dis1060
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.Kalayjian, Robert C ; Machekano, Rhoderick N ; Rizk, Nesrine ; Robbins, Gregory K ; Gandhi, Rajesh T ; Rodriguez, Benigno A ; Pollard, Richard B ; Lederman, Michael M ; Landay, Alan2010 Jun 15J Infect Dis12201
The prevalence and incidence of neurocognitive impairment in the HAART era.Robertson, Kevin R ; Smurzynski, Marlene ; Parsons, Thomas D ; Wu, Kunling ; Bosch, Ronald J ; Wu, Julia ; McArthur, Justin C ; Collier, Ann C ; Evans, Scott R ; Ellis, Ron J2007 Sep 12AIDS1421
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.Fife, Kenneth H ; Wu, Julia W ; Squires, Kathleen E ; Watts, D Heather ; Andersen, Janet W ; Brown, Darron R2009 Jul 1J Acquir Immune Defic Syndr351
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.Shivakoti, Rupak ; Christian, Parul ; Yang, Wei-Teng ; Gupte, Nikhil ; Mwelase, Noluthando ; Kanyama, Cecilia ; Pillay, Sandy ; Samaneka, Wadzanai ; Santos, Breno ; Poongulali, Selvamuthu ; Tripathy, Srikanth ; Riviere, Cynthia ; Berendes, Sima ; Lama, Javier R ; Cardoso, Sandra W ; Sugandhavesa, Patcharaphan ; Tang, Alice M ; Semba, Richa2016 FebClin Nutr135
Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371.Dykes, Carrie ; Mukherjee, A Lisa ; Bosch, Ronald J ; Connick, Elizabeth ; Volberding, Paul A ; Demeter, Lisa M2010 SepJ Acquir Immune Defic Syndr155
Prevention of HIV-1 infection with early antiretroviral therapy.Cohen, Myron S ; Chen, Ying Q ; McCauley, Marybeth ; Gamble, Theresa ; Hosseinipour, Mina C ; Kumarasamy, Nagalingeswaran ; Hakim, James G ; Kumwenda, Johnstone ; Grinsztejn, Beatriz ; Pilotto, Jose H S ; Godbole, Sheela V ; Mehendale, Sanjay ; Chariyalertsak, Suwat ; Santos, Breno R ; Mayer, Kenneth H ; Hoffman, Irving F ; Eshleman, Susan2011 Aug 11N Engl J Med6365
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.Cohn, Susan E ; Umbleja, Triin ; Mrus, Joseph ; Bardeguez, Arlene D ; Andersen, Janet W ; Chesney, Margaret A2008 JanAIDS Patient Care STDS122
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.Currier, Judith S ; Kendall, Michelle A ; Henry, W Keith ; Alston-Smith, Beverly ; Torriani, Francesca J ; Tebas, Pablo ; Li, Yanjie ; Hodis, Howard N2007 May 31AIDS921
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.Stein, James H ; Ribaudo, Heather J ; Hodis, Howard N ; Brown, Todd T ; Tran, Thuy Tien T ; Yan, Mingzhu ; Brodell, Elizabeth Lauer ; Kelesidis, Theodore ; McComsey, Grace A ; Dubé, Michael P ; Murphy, Robert L ; Currier, Judith S2015 Sep 10AIDS1429
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.Wallis, Carole L ; Mellors, John W ; Venter, Willem D F ; Sanne, Ian ; Stevens, Wendy2011AIDS Res Treat2011
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.Hitti, Jane ; Andersen, Janet ; McComsey, Grace ; Liu, Tun ; Melvin, Ann ; Smith, Laura ; Stek, Alice ; Aberg, Judith ; Hull, Andrew ; Alston-Smith, Beverly ; Watts, D Heather ; Livingston, Elizabeth ; AIDS Clinical Trials Group 5084 Study Team2007 AprAm J Obstet Gynecol4196
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.Gupta, Samir K ; Komarow, Lauren ; Gulick, Roy M ; Pollard, Richard B ; Robbins, Gregory K ; Franceschini, Nora ; Szczech, Lynda A ; Koletar, Susan L ; Kalayjian, Robert C2009 Aug 15J Infect Dis4200
Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.Kalayjian, Robert C ; Wu, Kunling ; Evans, Scott ; Clifford, David B ; Pallaki, Muraldihar ; Currier, Judith S ; Smryzynski, Marlene2014 Sep 1J Acquir Immune Defic Syndr167
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity.Paul, Robert H ; Yiannoutsos, Constantin T ; Miller, Eric N ; Chang, Linda ; Marra, Christina M ; Schifitto, Giovanni ; Ernst, Thomas ; Singer, Elyse ; Richards, Todd ; Jarvik, G Jeffrey ; Price, Richard ; Meyerhoff, Dieter J ; Kolson, Dennis ; Ellis, Ronald J ; Gonzalez, Gilberto ; Lenkinski, Robert E ; Cohen, Ronald A ; Navia, Bradford A2007 SummerJ Neuropsychiatry Clin Neurosci319
Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial.Safren, Steven A ; Biello, Katie B ; Smeaton, Laura ; Mimiaga, Matthew J ; Walawander, Ann ; Lama, Javier R ; Rana, Aadia ; Nyirenda, Mulinda ; Kayoyo, Virginia M ; Samaneka, Wadzanai ; Joglekar, Anjali ; Celentano, David ; Martinez, Ana ; Remmert, Jocelyn E ; Nair, Aspara ; Lalloo, Umesh G ; Kumarasamy, Nagalingeswaran ; Hakim, James ; Ca2014PLoS One89
Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial.DiFrancesco, Robin ; Rosenkranz, Susan ; Mukherjee, A Lisa ; Demeter, Lisa M ; Jiang, Hongyu ; DiCenzo, Robert ; Dykes, Carrie ; Rinehart, Alex ; Albrecht, Mary ; Morse, Gene D2010 AugTher Drug Monit432
Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.Safren, Steven A ; Hendriksen, Ellen S ; Smeaton, Laura ; Celentano, David D ; Hosseinipour, Mina C ; Barnett, Ronald ; Guanira, Juan ; Flanigan, Timothy ; Kumarasamy, N ; Klingman, Karin ; Campbell, Thomas2012 FebAIDS Behav216
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.Tsibris, Athe M N ; Korber, Bette ; Arnaout, Ramy ; Russ, Carsten ; Lo, Chien-Chi ; Leitner, Thomas ; Gaschen, Brian ; Theiler, James ; Paredes, Roger ; Su, Zhaohui ; Hughes, Michael D ; Gulick, Roy M ; Greaves, Wayne ; Coakley, Eoin ; Flexner, Charles ; Nusbaum, Chad ; Kuritzkes, Daniel R2009PLoS One54
Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.Ferreira, Manuel A R ; Mangino, Massimo ; Brumme, Chanson J ; Zhao, Zhen Zhen ; Medland, Sarah E ; Wright, Margaret J ; Nyholt, Dale R ; Gordon, Scott ; Campbell, Megan ; McEvoy, Brian P ; Henders, Anjali ; Evans, David M ; Lanchbury, Jerry S ; Pereyra, Florencia ; International HIV Controllers Study ; Walker, Bruce D ; Haas, David W ; Sor2010 JanAm J Hum Genet186
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.Ribaudo, Heather J ; Smith, Kimberly Y ; Robbins, Gregory K ; Flexner, Charles ; Haubrich, Richard ; Chen, Yun ; Fischl, Margaret A ; Schackman, Bruce R ; Riddler, Sharon A ; Gulick, Roy M2013 DecClin Infect Dis1157
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.Schackman, Bruce R ; Ribaudo, Heather J ; Krambrink, Amy ; Hughes, Valery ; Kuritzkes, Daniel R ; Gulick, Roy M2007 Dec 15J Acquir Immune Defic Syndr546
Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.Simoni, Jane M ; Huh, David ; Wilson, Ira B ; Shen, Jie ; Goggin, Kathy ; Reynolds, Nancy R ; Remien, Robert H ; Rosen, Marc I ; Bangsberg, David R ; Liu, Honghu2012 Aug 15J Acquir Immune Defic Syndr560
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.La Rosa, Alberto M ; Harrison, Linda J ; Taiwo, Babafemi ; Wallis, Carole L ; Zheng, Lu ; Kim, Peter ; Kumarasamy, Nagalingeswaran ; Hosseinipour, Mina C ; Jarocki, Bernadette ; Mellors, John W ; Collier, Ann C ; ACTG A5273 Study Group2016 JunLancet HIV63
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.Albrecht, Mary ; Mukherjee, A Lisa ; Tierney, Camlin ; Morse, Gene D ; Dykes, Carrie ; Klingman, Karin L ; Demeter, Lisa M2011 Jul-AugHIV Clin Trials412
A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings.Erlandson, Kristine M ; Taejaroenkul, Sineenart ; Smeaton, Laura ; Gupta, Amita ; Singini, Isaac L ; Lama, Javier R ; Mngqibisa, Rosie ; Firnhaber, Cynthia ; Cardoso, Sandra Wagner ; Kanyama, Cecilia ; Machado da Silva, Andre L ; Hakim, James G ; Kumarasamy, Nagalingeswaran ; Campbell, Thomas B ; Hughes, Michael D2015 SepOpen Forum Infect Dis32
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Peters, Marion G ; Andersen, Janet ; Lynch, Patrick ; Liu, Tun ; Alston-Smith, Beverly ; Brosgart, Carol L ; Jacobson, Jeffrey M ; Johnson, Victoria A ; Pollard, Richard B ; Rooney, James F ; Sherman, Kenneth E ; Swindells, Susan ; Polsky, Bruce ; ACTG Protocol A5127 Team2006 NovHepatology544
A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.Jacobson, Jeffrey M ; Wang, Hongying ; Bordi, Rebeka ; Zheng, Lu ; Gross, Barry H ; Landay, Alan L ; Spritzler, John ; Routy, Jean-Pierre ; Benson, Constance ; Aberg, Judith ; Tebas, Pablo ; Haas, David W ; Tiu, Jennifer ; Coughlin, Kristine ; Purdue, Lynette ; Sekaly, Rafick-Pierre ; AIDS Clinical Trials Group (ACTG) A5212 Protocol Team2014 Aug 1J Acquir Immune Defic Syndr466
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen.Fischl, Margaret A ; Collier, Ann C ; Mukherjee, A Lisa ; Feinberg, Judith E ; Demeter, Lisa M ; Tebas, Pablo ; Giuliano, Marina ; Dehlinger, Marjorie ; Garren, Kevin ; Brizz, Barbara ; Bassett, Roland2007 Jan 30AIDS321
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).Kilby, J Michael ; Bucy, R Pat ; Mildvan, Donna ; Fischl, Margaret ; Santana-Bagur, Jorge ; Lennox, Jeff ; Pilcher, Chris ; Zolopa, Andrew ; Lawrence, Jody ; Pollard, Richard B ; Habib, Raphaelle El ; Sahner, David ; Fox, Lawrence ; Aga, Evgenia ; Bosch, Ronald J ; Mitsuyasu, Ronald ; Adult AIDS Clinical Trials Group A5024 Protocol Team2006 Dec 15J Infect Dis12194
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.Hammer, Scott M ; Ribaudo, Heather ; Bassett, Roland ; Mellors, John W ; Demeter, Lisa M ; Coombs, Robert W ; Currier, Judith ; Morse, Gene D ; Gerber, John G ; Martinez, Ana I ; Spreen, William ; Fischl, Margaret A ; Squires, Kathleen E ; AIDS Clinical Trials Group (ACTG) 372A Study Team2010 Nov-DecHIV Clin Trials611
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.Riddler, Sharon A ; Jiang, Hongyu ; Tenorio, Allan ; Huang, Hairong ; Kuritzkes, Daniel R ; Acosta, Edward P ; Landay, Alan ; Bastow, Barbara ; Haas, David W ; Tashima, Karen T ; Jain, Mamta K ; Deeks, Steven G ; Bartlett, John A2007Antivir Ther412
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.Collier, Ann C ; Tierney, Camlin ; Downey, Gerald F ; Eshleman, Susan H ; Kashuba, Angela ; Klingman, Karin ; Vergis, Emanuel N ; Pakes, Gary E ; Rooney, James F ; Rinehart, Alex ; Mellors, John W ; AIDS Clinical Trials Group Protocol A5143 Team2008 Mar-AprHIV Clin Trials29
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.Gandhi, Rajesh T ; O'Neill, David ; Bosch, Ronald J ; Chan, Ellen S ; Bucy, R Pat ; Shopis, Janet ; Baglyos, Lynn ; Adams, Elizabeth ; Fox, Lawrence ; Purdue, Lynette ; Marshak, Ann ; Flynn, Theresa ; Masih, Reena ; Schock, Barbara ; Mildvan, Donna ; Schlesinger, Sarah J ; Marovich, Mary A ; Bhardwaj, Nina ; Jacobson, Jeffrey M ; AIDS Clin2009 Oct 9Vaccine4327
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.Evans, Scott R ; Simpson, David M ; Kitch, Douglas W ; King, Agnes ; Clifford, David B ; Cohen, Bruce A ; McArthur, Justin C ; Neurologic AIDS Research Consortium ; AIDS Clinical Trials Group2007PLoS One62
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.Bosch, Ronald J ; Pollard, Richard B ; Landay, Alan ; Aga, Evgenia ; Fox, Lawrence ; Mitsuyasu, Ronald ; AIDS Clinical Trials Group A5132 Team2011 JunJ Interferon Cytokine Res631
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.Demeter, Lisa M ; Jiang, Hongyu ; Mukherjee, A Lisa ; Morse, Gene D ; DiFrancesco, Robin ; DiCenzo, Robert ; Dykes, Carrie ; Sista, Prakash ; Bacheler, Lee ; Klingman, Karin ; Rinehart, Alex ; Albrecht, Mary2009 Jan 28AIDS323
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.Benson, Constance A ; Vaida, Florin ; Havlir, Diane V ; Downey, Gerald F ; Lederman, Michael M ; Gulick, Roy M ; Glesby, Marshall J ; Wantman, Michael ; Bixby, Christian J ; Rinehart, Alex R ; Snyder, Sally ; Wang, Rui ; Patel, Sheran ; Mellors, John W ; ACTG A5086 Study Team2006 Nov 1J Infect Dis9194
Rationale and uses of a public HIV drug-resistance database.Shafer, Robert W2006 Sep 15J Infect Dis194 Suppl 1
Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy.Timmermans, Eveline C ; Tebas, Pablo ; Ruiter, Jos P N ; Wanders, Ronald J A ; de Ronde, Anthony ; de Baar, Michel P2006 JunClin Chem652
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.Wilkin, Timothy J ; Goetz, Mathew Bidwell ; Leduc, Robert ; Skowron, Gail ; Su, Zhaohui ; Chan, Ellen S ; Heera, Jayyant ; Chapman, Doug ; Spritzler, John ; Reeves, Jacqueline D ; Gulick, Roy M ; Coakley, Eoin2011 Apr 1Clin Infect Dis752
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.Kendall, Michelle A ; Andersen, Janet W ; van der Horst, Charles2006 JunContemp Clin Trials327
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Longenecker, Chris T ; Kitch, Douglas ; Sax, Paul E ; Daar, Eric S ; Tierney, Camlin ; Gupta, Samir K ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2015 Jun 1J Acquir Immune Defic Syndr269
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.Tashima, Karen T ; Mollan, Katie R ; Na, Lumine ; Gandhi, Rajesh T ; Klingman, Karin L ; Fichtenbaum, Carl J ; Andrade, Adriana ; Johnson, Victoria A ; Eron, Joseph J ; Smeaton, Laura ; Haubrich, Richard H2015 AugHIV Clin Trials416
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.Wilkin, Timothy J ; McKinnon, John E ; DiRienzo, A Gregory ; Mollan, Katie ; Fletcher, Courtney V ; Margolis, David M ; Bastow, Barbara ; Thal, Gary ; Woodward, William ; Godfrey, Catherine ; Wiegand, Ann ; Maldarelli, Frank ; Palmer, Sarah ; Coffin, John M ; Mellors, John W ; Swindells, Susan2009 Mar 15J Infect Dis6199
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.Swindells, Susan ; DiRienzo, A Gregory ; Wilkin, Timothy ; Fletcher, Courtney V ; Margolis, David M ; Thal, Gary D ; Godfrey, Catherine ; Bastow, Barbara ; Ray, M Graham ; Wang, Hongying ; Coombs, Robert W ; McKinnon, John ; Mellors, John W ; AIDS Clinical Trials Group 5201 Study Team2006 Aug 16JAMA7296
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.Weinberg, Adriana ; Bosch, Ronald ; Bennett, Kara ; Tovar-Salazar, Adriana ; Benson, Constance A ; Collier, Ann C ; Zolopa, Andrew ; Gulick, Roy M ; Wohl, David ; Polsky, Bruce ; Erice, Alejo ; Jacobson, Mark A2014 May 1J Acquir Immune Defic Syndr166
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study.Smurzynski, Marlene ; Wu, Kunling ; Benson, Constance A ; Bosch, Ronald J ; Collier, Ann C ; Koletar, Susan L2010 SepJ Acquir Immune Defic Syndr155
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.Li, Jonathan Z ; Paredes, Roger ; Ribaudo, Heather J ; Svarovskaia, Evguenia S ; Kozal, Michael J ; Hullsiek, Katherine H ; Miller, Michael D ; Bangsberg, David R ; Kuritzkes, Daniel R2012 Jan 14AIDS226
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.Luetkemeyer, Anne F ; Rosenkranz, Susan L ; Lu, Darlene ; Marzan, Florence ; Ive, Prudence ; Hogg, Evelyn ; Swindells, Susan ; Benson, Constance A ; Grinsztejn, Beatriz ; Sanne, Ian M ; Havlir, Diane V ; Aweeka, Francesca ; Adult AIDS Clinical Trials Group A5221 Study Team2013 AugClin Infect Dis457
The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patients.Wilkin, Timothy J ; Ribaudo, Heather R ; Tenorio, Allan R ; Gulick, Roy M2010 Nov-DecHIV Clin Trials611
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study.Li, Jonathan Z ; Heisey, Andrea ; Ahmed, Hayat ; Wang, Hongying ; Zheng, Lu ; Carrington, Mary ; Wrin, Terri ; Schooley, Robert T ; Lederman, Michael M ; Kuritzkes, Daniel R ; ACTG A5197 Study Team2014 Nov 28AIDS1828
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.Graham, Camilla S ; Wells, Annalee ; Liu, Tun ; Sherman, Kenneth E ; Peters, Marion ; Chung, Raymond T ; Bhan, Atul K ; Andersen, Janet ; Koziel, Margaret James ; ACTG 5071 Study Team2006 Feb 14AIDS320
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.Paul, Robert H ; Ernst, Thomas ; Brickman, Adam M ; Yiannoutsos, Constantin T ; Tate, David F ; Cohen, Ronald A ; Navia, Bradford A ; ACTG 301 team ; ACTG 700 team ; HIV MRS Consortium2008 SepJ Int Neuropsychol Soc514
Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).Touzard Romo, F ; Smeaton, L M ; Campbell, T B ; Riviere, C ; Mngqibisa, R ; Nyirenda, M ; Supparatpinyo, K ; Kumarasamy, N ; Hakim, J G ; Flanigan, T P2014 Nov-DecHIV Clin Trials615
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.Mwafongo, Albert ; Nkanaunena, Kondwani ; Zheng, Yu ; Hogg, Evelyn ; Samaneka, Wadzanai ; Mulenga, Lloyd ; Siika, Abraham ; Currier, Judith ; Lockman, Shahin ; Hughes, Michael D ; Hosseinipour, Mina ; AIDS Clinical Trial Group (ACTG) A5208 Team2014 May 15AIDS828
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.Skowron, Gail ; Spritzler, John G ; Weidler, Jodi ; Robbins, Gregory K ; Johnson, Victoria A ; Chan, Ellen S ; Asmuth, David M ; Gandhi, Rajesh T ; Lie, Yolanda ; Bates, Michael ; Pollard, Richard B ; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences2009 Mar 1J Acquir Immune Defic Syndr350
A resampling-based approach to multiple testing with uncertainty in phase.Foulkes, Andrea S ; DeGruttola, Victor G2007Int J Biostat13
Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices.Yang, Yang ; Degruttola, Victor2012Int J Biostat18
Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173.Gandhi, Rajesh T ; Bosch, Ronald J ; Aga, Evgenia ; Bedison, Margaret A ; Bastow, Barbara ; Schmitz, John L ; Siliciano, Janet D ; Siliciano, Robert F ; Eron, Joseph J ; Mellors, John W ; ACTG A5173 team2013Antivir Ther418
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.Su, Zhaohui ; Gulick, Roy M ; Krambrink, Amy ; Coakley, Eoin ; Hughes, Michael D ; Han, Dong ; Flexner, Charles ; Wilkin, Timothy J ; Skolnik, Paul R ; Greaves, Wayne L ; Kuritzkes, Daniel R ; Reeves, Jacqueline D ; AIDS Clinical Trials Group A5211 Team2009 Dec 1J Infect Dis11200
Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors.Clark, Shauna A ; Shulman, Nancy S ; Bosch, Ronald J ; Mellors, John W2006 Apr 24AIDS720
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.Tenorio, Allan R ; Chan, Ellen S ; Bosch, Ronald J ; Macatangay, Bernard J C ; Read, Sarah W ; Yesmin, Suria ; Taiwo, Babafemi ; Margolis, David M ; Jacobson, Jeffrey M ; Landay, Alan L ; Wilson, Cara C ; A5286 Team2015 Mar 1J Infect Dis5211
Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.Grant, Philip M ; Komarow, Lauren ; Andersen, Janet ; Sereti, Irini ; Pahwa, Savita ; Lederman, Michael M ; Eron, Joseph ; Sanne, Ian ; Powderly, William ; Hogg, Evelyn ; Suckow, Carol ; Zolopa, Andrew2010PLoS One75
Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.Messer, Karen ; Vaida, Florin ; Hogan, Christine2006 DecContemp Clin Trials627
The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons.Kang, Minhee ; Chung, Raymond T2007 Nov 1J Acquir Immune Defic Syndr346
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.Boltz, Valerie F ; Zheng, Yu ; Lockman, Shahin ; Hong, Feiyu ; Halvas, Elias K ; McIntyre, James ; Currier, Judith S ; Chibowa, Margret C ; Kanyama, Cecelia ; Nair, Apsara ; Owino-Ong'or, Willis ; Hughes, Michael ; Coffin, John M ; Mellors, John W2011 May 31Proc Natl Acad Sci U S A22108
Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.Shiboski, C H ; Chen, H ; Ghannoum, M A ; Komarow, L ; Evans, S ; Mukherjee, P K ; Isham, N ; Katzenstein, D ; Asmelash, A ; Omozoarhe, A E ; Gengiah, S ; Allen, R ; Tripathy, S ; Swindells, S ; AIDS Clinical Trials Group Network and Oral HIV/AIDS Research Alliance2014 JunInt J Tuberc Lung Dis618
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.Sulkowski, Mark S ; Kang, Minhee ; Matining, Roy ; Wyles, David ; Johnson, Victoria A ; Morse, Gene D ; Amorosa, Valerianna ; Bhattacharya, Debika ; Coughlin, Kristine ; Wong-Staal, Flossie ; Glesby, Marshall J ; AIDS Clinical Trials Group A5277 Protocol Team2014 Mar 1J Infect Dis5209
Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148.Dubé, Michael P ; Wu, Julia W ; Aberg, Judith A ; Deeg, Mark A ; Alston-Smith, Beverly L ; McGovern, Mark E ; Lee, Daniel ; Shriver, Sharon L ; Martinez, Ana I ; Greenwald, Martha ; Stein, James H ; AIDS Clinical Trials Group A5148 Study Team2006Antivir Ther811
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.Jacobson, Jeffrey M ; Zheng, Lu ; Wilson, Cara C ; Tebas, Pablo ; Matining, Roy M ; Egan, Michael A ; Eldridge, John ; Landay, Alan L ; Clifford, David B ; Luetkemeyer, Anne F ; Tiu, Jennifer ; Martinez, Ana L ; Janik, Jennifer ; Spitz, Teresa A ; Hural, John ; McElrath, Juliana ; Frahm, Nicole ; ACTG A5281 Protocol Team2016 Feb 1J Acquir Immune Defic Syndr271
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.Wilkin, Timothy ; Lee, Jeannette Y ; Lensing, Shelly Y ; Stier, Elizabeth A ; Goldstone, Stephen E ; Berry, J Michael ; Jay, Naomi ; Aboulafia, David ; Cohn, David L ; Einstein, Mark H ; Saah, Alfred ; Mitsuyasu, Ronald T ; Palefsky, Joel M2010 Oct 15J Infect Dis8202
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection.Rosenberg, Eric S ; Graham, Barney S ; Chan, Ellen S ; Bosch, Ronald J ; Stocker, Vicki ; Maenza, Janine ; Markowitz, Martin ; Little, Susan ; Sax, Paul E ; Collier, Ann C ; Nabel, Gary ; Saindon, Suzanne ; Flynn, Theresa ; Kuritzkes, Daniel ; Barouch, Dan H ; AIDS Clinical Trials Group A5187 Team2010PLoS One55
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.Watts, D Heather ; Park, Jeong-Gun ; Cohn, Susan E ; Yu, Song ; Hitti, Jane ; Stek, Alice ; Clax, Pamela A ; Muderspach, Laila ; Lertora, Juan J L2008 FebContraception277
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.Rodriguez, Benigno ; Asmuth, David M ; Matining, Roy M ; Spritzler, John ; Jacobson, Jeffrey M ; Mailliard, Robbie B ; Li, Xiao-Dong ; Martinez, Ana I ; Tenorio, Allan R ; Lori, Franco ; Lisziewicz, Julianna ; Yesmin, Suria ; Rinaldo, Charles R ; Pollard, Richard B2013 Dec 1J Acquir Immune Defic Syndr464
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.Asmuth, David M ; Murphy, Robert L ; Rosenkranz, Susan L ; Lertora, Juan J L ; Kottilil, Shyam ; Cramer, Yoninah ; Chan, Ellen S ; Schooley, Robert T ; Rinaldo, Charles R ; Thielman, Nathan ; Li, Xiao-Dong ; Wahl, Sharon M ; Shore, Jessica ; Janik, Jennifer ; Lempicki, Richard A ; Simpson, Yaa ; Pollard, Richard B ; AIDS Clinical Trials Gr2010 Jun 1J Infect Dis11201
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.Dooley, Kelly E ; Park, Jeong-Gun ; Swindells, Susan ; Allen, Reena ; Haas, David W ; Cramer, Yoninah ; Aweeka, Francesca ; Wiggins, Ilene ; Gupta, Amita ; Lizak, Patricia ; Qasba, Sonia ; van Heeswijk, Rolf ; Flexner, Charles ; ACTG 5267 Study Team2012 Apr 15J Acquir Immune Defic Syndr559
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.Davey, Richard T ; Pertel, Peter E ; Benson, Alice ; Cassell, Delanie J ; Gazzard, Brian G ; Holodniy, Mark ; Lalezari, Jacob P ; Levy, Yves ; Mitsuyasu, Ronald T ; Palella, Frank J ; Pollard, Richard B ; Rajagopalan, Prabhu ; Saag, Michael S ; Salata, Robert A ; Sha, Beverly E ; Choudhri, Shurjeel2008 FebJ Interferon Cytokine Res228
Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.Swindells, S ; Komarow, L ; Tripathy, S ; Cain, K P ; MacGregor, R R ; Achkar, J M ; Gupta, A ; Veloso, V G ; Asmelash, A ; Omoz-Oarhe, A E ; Gengiah, S ; Lalloo, U ; Allen, R ; Shiboski, C ; Andersen, J ; Qasba, S S ; Katzenstein, D K ; AIDS Clinical Trials Group 5253 Study Team2013 AprInt J Tuberc Lung Dis417
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.Vardhanabhuti, Saran ; Ribaudo, Heather J ; Landovitz, Raphael J ; Ofotokun, Ighovwerha ; Lennox, Jeffrey L ; Currier, Judith S ; Olson, Lana M ; Haas, David W2015 SepOpen Forum Infect Dis32
Second assessment of NeuroAIDS in Africa.Robertson, Kevin ; Kopnisky, Kathy ; Hakim, James ; Merry, Concepta ; Nakasujja, Noeline ; Hall, Colin ; Traore, Moussa ; Sacktor, Ned ; Clifford, David ; Newton, Charles ; Van Rie, Annelies ; Holding, Penny ; Clements, Janice ; Zink, Christine ; Mielk, Jens ; Hosseinipour, Mina ; Lalloo, Umesh ; Amod, Farida ; Marra, Christina ; Evans, Sc2008 AprJ Neurovirol214
Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.Haas, David W ; Kwara, Awewura ; Richardson, Danielle M ; Baker, Paxton ; Papageorgiou, Ioannis ; Acosta, Edward P ; Morse, Gene D ; Court, Michael H2014 AugJ Antimicrob Chemother869
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.Palmer, Sarah ; Boltz, Valerie ; Maldarelli, Frank ; Kearney, Mary ; Halvas, Elias K ; Rock, Diane ; Falloon, Judith ; Davey, Richard T ; Dewar, Robin L ; Metcalf, Julia A ; Mellors, John W ; Coffin, John M2006 Mar 21AIDS520
Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression.Paris, Robert M ; Petrovas, Constantinos ; Ferrando-Martinez, Sara ; Moysi, Eirini ; Boswell, Kristin L ; Archer, Eva ; Yamamoto, Takuya ; Ambrozak, David ; Casazza, Joseph P ; Haubrich, Richard ; Connors, Mark ; Ake, Julie ; Kim, Jerome H ; Koup, Richard A2015PLoS One1210
Selegiline and oxidative stress in HIV-associated cognitive impairment.Schifitto, G ; Yiannoutsos, C T ; Ernst, T ; Navia, B A ; Nath, A ; Sacktor, N ; Anderson, C ; Marra, C M ; Clifford, D B ; ACTG 5114 Team2009 Dec 8Neurology2373
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.Evans, Scott R ; Yeh, Tzu-min ; Sacktor, Ned ; Clifford, David B ; Simpson, David ; Miller, Eric N ; Ellis, Ronald J ; Valcour, Victor ; Marra, Christina M ; Millar, Linda ; Schifitto, Giovanni ; AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium2007 Nov-DecHIV Clin Trials68
Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS.Delahunty, Tom ; Bushman, Lane ; Fletcher, Courtney V2006 Jan 2J Chromatogr B Analyt Technol Biomed Life Sci1830
Serosorting can potentially increase HIV transmissions.Butler, David M ; Smith, Davey M2007 May 31AIDS921
The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.Hogan, Christine M ; Degruttola, Victor ; Sun, Xin ; Fiscus, Susan A ; Del Rio, Carlos ; Hare, C Bradley ; Markowitz, Martin ; Connick, Elizabeth ; Macatangay, Bernard ; Tashima, Karen T ; Kallungal, Beatrice ; Camp, Rob ; Morton, Tia ; Daar, Eric S ; Little, Susan ; A5217 Study Team2012 Jan 1J Infect Dis1205
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.Sandler, Netanya G ; Zhang, Xinyan ; Bosch, Ronald J ; Funderburg, Nicholas T ; Choi, Andrew I ; Robinson, Janet K ; Fine, Derek M ; Coombs, Robert W ; Jacobson, Jeffrey M ; Landay, Alan L ; Douek, Daniel C ; Tressler, Randall ; Read, Sarah W ; Wilson, Cara C ; Deeks, Steven G ; Lederman, Michael M ; Gandhi, Rajesh T ; AIDS Clinical Trials2014 Nov 15J Infect Dis10210
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.Venuto, Charles S ; Mollan, Katie ; Ma, Qing ; Daar, Eric S ; Sax, Paul E ; Fischl, Margaret ; Collier, Ann C ; Smith, Kimberly Y ; Tierney, Camlin ; Morse, Gene D2014 DecJ Antimicrob Chemother1269
Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.Umeh, Obi C ; Currier, Judith S ; Park, Jeong-Gun ; Cramer, Yoninah ; Hermes, Ashwaq E ; Fletcher, Courtney V2011 DecJ Clin Pharmacol1251
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Meier, Angela ; Chang, J Judy ; Chan, Ellen S ; Pollard, Richard B ; Sidhu, Harlyn K ; Kulkarni, Smita ; Wen, Tom Fang ; Lindsay, Robert J ; Orellana, Liliana ; Mildvan, Donna ; Bazner, Suzane ; Streeck, Hendrik ; Alter, Galit ; Lifson, Jeffrey D ; Carrington, Mary ; Bosch, Ronald J ; Robbins, Gregory K ; Altfeld, Marcus2009 AugNat Med815
Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.Grinsztejn, Beatriz ; Smeaton, Laura ; Barnett, Ronald ; Klingman, Karin ; Hakim, James ; Flanigan, Timothy ; Kumarasamy, N ; Campbell, Thomas ; Currier, Judith ; PEARLS study team of the ACTG2011Antivir Ther716
Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.Mathad, Jyoti S ; Gupte, Nikhil ; Balagopal, Ashwin ; Asmuth, David ; Hakim, James ; Santos, Breno ; Riviere, Cynthia ; Hosseinipour, Mina ; Sugandhavesa, Patcharaphan ; Infante, Rosa ; Pillay, Sandy ; Cardoso, Sandra W ; Mwelase, Noluthando ; Pawar, Jyoti ; Berendes, Sima ; Kumarasamy, Nagalingeswaran ; Andrade, Bruno B ; Campbell, Thomas2016 May 27J Acquir Immune Defic Syndr
Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.Chow, Dominic ; Chen, Huichao ; Glesby, Marshall J ; Busti, Anthony ; Souza, Scott ; Andersen, Janet ; Kohrs, Sharon ; Wu, Julia ; Koletar, Susan L2009 Oct 23AIDS1623
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma.Yuste, Eloisa ; Sanford, Hannah B ; Carmody, Jill ; Bixby, Jacqueline ; Little, Susan ; Zwick, Michael B ; Greenough, Tom ; Burton, Dennis R ; Richman, Douglas D ; Desrosiers, Ronald C ; Johnson, Welkin E2006 MarJ Virol680
Simplification of the research diagnosis of HIV-associated sensory neuropathy.Evans, Scott R ; Clifford, David B ; Kitch, Douglas W ; Goodkin, Karl ; Schifitto, Giovanni ; McArthur, Justin C ; Simpson, David M2008 Nov-DecHIV Clin Trials69
Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Robbins, Gregory K ; Testa, Marcia A ; Su, Max ; Safren, Steven A ; Morse, Gene ; Lammert, Sara ; Shafer, Robert W ; Reynolds, Nancy R ; Chesney, Margaret A2013 Sep-OctHIV Clin Trials514
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.Li, Jonathan Z ; Etemad, Behzad ; Ahmed, Hayat ; Aga, Evgenia ; Bosch, Ronald J ; Mellors, John W ; Kuritzkes, Daniel R ; Lederman, Michael M ; Para, Michael ; Gandhi, Rajesh T2016 Jan 28AIDS330
Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332.Danoff, Ann ; Kendall, Michelle A ; Currier, Judith S ; Kelesidis, Theodoros ; Schmidt, Ann Marie ; Aberg, Judith A2016 AugInflammation439
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Tenorio, Allan R ; Zheng, Yu ; Bosch, Ronald J ; Krishnan, Supriya ; Rodriguez, Benigno ; Hunt, Peter W ; Plants, Jill ; Seth, Arjun ; Wilson, Cara C ; Deeks, Steven G ; Lederman, Michael M ; Landay, Alan L2014 Oct 15J Infect Dis8210
S-phase entry leads to cell death in circulating T cells from HIV-infected persons.Sieg, Scott F ; Bazdar, Douglas A ; Lederman, Michael M2008 JunJ Leukoc Biol683
Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort.Brown, Todd T ; Smurzynski, Marlene ; Wu, Kunling ; Bosch, Ronald J ; McComsey, Grace A2009Antivir Ther614
Statistical determination of threshold for cellular division in the CFSE-labeling assay.Liu, Dacheng ; Yu, Jie ; Chen, Huiyuan ; Reichman, Richard ; Wu, Hulin ; Jin, Xia2006 May 30J Immunol Methods1-2312
A statistical framework for quantile equivalence clinical trials with application to pharmacokinetic studies that bridge from HIV-infected adults to children.Pei, Lixia ; Hughes, Michael D2008 DecBiometrics464
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.Schouten, Jeffrey T ; Krambrink, Amy ; Ribaudo, Heather J ; Kmack, Anne ; Webb, Nancy ; Shikuma, Cecilia ; Kuritzkes, Daniel R ; Gulick, Roy M2010 Mar 1Clin Infect Dis550
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.Kalayjian, Robert C ; Franceschini, Nora ; Gupta, Samir K ; Szczech, Lynda A ; Mupere, Ezekiel ; Bosch, Ronald J ; Smurzynski, Marlene ; Albert, Jeffrey M2008 Feb 19AIDS422
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.Yamamoto, Takuya ; Price, David A ; Casazza, Joseph P ; Ferrari, Guido ; Nason, Martha ; Chattopadhyay, Pratip K ; Roederer, Mario ; Gostick, Emma ; Katsikis, Peter D ; Douek, Daniel C ; Haubrich, Richard ; Petrovas, Constantinos ; Koup, Richard A2011 May 5Blood18117
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).Sherman, Kenneth E ; Andersen, Janet W ; Butt, Adeel A ; Umbleja, Triin ; Alston, Beverly ; Koziel, Margaret J ; Peters, Marion G ; Sulkowski, Mark ; Goodman, Zachary D ; Chung, Raymond T ; AIDS Clinical Trials Group A5178 Study Team2010 Dec 15J Acquir Immune Defic Syndr555
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).Tebas, Pablo ; Zhang, Jiameng ; Yarasheski, Kevin ; Evans, Scott ; Fischl, Margaret A ; Shevitz, Abby ; Feinberg, Judith ; Collier, Ann C ; Shikuma, Cecilia ; Brizz, Barbara ; Sattler, Fred ; AIDS Clinical Trials Group (ACTG)2007 Jun 1J Acquir Immune Defic Syndr245
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.Hulgan, Todd ; Robbins, Gregory K ; Kalams, Spyros A ; Samuels, David C ; Grady, Benjamin ; Shafer, Robert ; Murdock, Deborah G ; Selph, Doug ; Haas, David W ; Pollard, Richard B ; AIDS Clinical Trials Group2012PLoS One87
Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial.Reynolds, Nancy R ; Testa, Marcia A ; Su, Max ; Chesney, Margaret A ; Neidig, Judith L ; Frank, Ian ; Smith, Scott ; Ickovics, Jeannette ; Robbins, Gregory K ; AIDS Clinical Trials Group 731 and 384 Teams2008 Jan 1J Acquir Immune Defic Syndr147
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi.Johnson, Derek C ; Chasela, Charles ; Maliwichi, Madalitso ; Mwafongo, Albert ; Akinkuotu, Adesola ; Moses, Agness ; Jamieson, Denise J ; Kourtis, Athena P ; King, Caroline C ; van der Horst, Charlie ; Hosseinipour, Mina C2012PLoS One77
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.Wood, Brian R ; Komarow, Lauren ; Zolopa, Andrew R ; Finkelman, Malcolm A ; Powderly, William G ; Sax, Paul E2013 Mar 27AIDS627
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.Mulligan, Kathleen ; Zackin, Robert ; Von Roenn, Jamie H ; Chesney, Margaret A ; Egorin, Merrill J ; Sattler, Fred R ; Benson, Constance A ; Liu, Tun ; Umbleja, Triin ; Shriver, Sharon ; Auchus, Richard J ; Schambelan, Morris ; ACTG 313 Study Team2007 FebJ Clin Endocrinol Metab292
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.Andrade, Adriana ; Rosenkranz, Susan L ; Cillo, Anthony R ; Lu, Darlene ; Daar, Eric S ; Jacobson, Jeffrey M ; Lederman, Michael ; Acosta, Edward P ; Campbell, Thomas ; Feinberg, Judith ; Flexner, Charles ; Mellors, John W ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group A5248 Team2013 SepJ Infect Dis6208
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.Gulick, Roy M ; Ribaudo, Heather J ; Shikuma, Cecilia M ; Lalama, Christina ; Schackman, Bruce R ; Meyer, William A ; Acosta, Edward P ; Schouten, Jeffrey ; Squires, Kathleen E ; Pilcher, Christopher D ; Murphy, Robert L ; Koletar, Susan L ; Carlson, Margrit ; Reichman, Richard C ; Bastow, Barbara ; Klingman, Karin L ; Kuritzkes, Daniel R 2006 Aug 16JAMA7296
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.Wilkin, Timothy J ; Su, Zhaohui ; Krambrink, Amy ; Long, Jianmin ; Greaves, Wayne ; Gross, Robert ; Hughes, Michael D ; Flexner, Charles ; Skolnik, Paul R ; Coakley, Eoin ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; Gulick, Roy M2010 AugJ Acquir Immune Defic Syndr554
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.Havlir, Diane V ; Kendall, Michelle A ; Ive, Prudence ; Kumwenda, Johnstone ; Swindells, Susan ; Qasba, Sarojini S ; Luetkemeyer, Anne F ; Hogg, Evelyn ; Rooney, James F ; Wu, Xingye ; Hosseinipour, Mina C ; Lalloo, Umesh ; Veloso, Valdilea G ; Some, Fatuma F ; Kumarasamy, N ; Padayatchi, Nesri ; Santos, Breno R ; Reid, Stewart ; Hakim, Ja2011 Oct 20N Engl J Med16365
TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.Yonkers, Nicole L ; Rodriguez, Benigno ; Milkovich, Kimberly A ; Asaad, Robert ; Lederman, Michael M ; Heeger, Peter S ; Anthony, Donald D2007 Apr 1J Immunol7178
Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.Funderburg, Nicholas ; Luciano, Angel A ; Jiang, Wei ; Rodriguez, Benigno ; Sieg, Scott F ; Lederman, Michael M2008PLoS One43
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants.Mukherjee, Pranab K ; Chen, Huichao ; Patton, Lauren L ; Evans, Scott ; Lee, Anthony ; Kumwenda, Johnstone ; Hakim, James ; Masheto, Gaerolwe ; Sawe, Frederick ; Pho, Mai T ; Freedberg, Kenneth A ; Shiboski, Caroline H ; Ghannoum, Mahmoud A ; Salata, Robert A ; Oral HIVAIDS Research Alliance (OHARA)AIDS Clinical Trials Group (ACTG) 5265 Te2017 Jan 02AIDS131
Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir.Ouyang, Zhengyu ; Buzon, Maria J ; Zheng, Lu ; Sun, Hong ; Yu, Xu G ; Bosch, Ronald J ; Mellors, John W ; Eron, Joseph J ; Gandhi, Rajesh T ; Lichterfeld, Mathias2015 AprOpen Forum Infect Dis22
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.Almeida, Coral-Ann M ; Bronke, Corine ; Roberts, Steven G ; McKinnon, Elizabeth ; Keane, Niamh M ; Chopra, Abha ; Kadie, Carl ; Carlson, Jonathan ; Haas, David W ; Riddler, Sharon A ; Haubrich, Richard ; Heckerman, David ; Mallal, Simon ; John, Mina2011 Sep 1J Immunol5187
Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.Kassaye, Seble G ; Grossman, Zehava ; Balamane, Maya ; Johnston-White, Betsy ; Liu, Chenglong ; Kumar, Princy ; Young, Mary ; Sneller, Michael C ; Sereti, Irini ; Dewar, Robin ; Rehm, Catherine ; Meyer, William ; Shafer, Robert ; Katzenstein, David ; Maldarelli, Frank2016 Jun 15Clin Infect Dis
Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies.Patterson, Kristine B ; Cohn, Susan E ; Uyanik, Jennifer ; Hughes, Michael ; Smurzynski, Marlene ; Eron, Joseph J2009 Aug 1Clin Infect Dis349
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.Fichtenbaum, Carl J ; Yeh, Tzu-min ; Evans, Scott R ; Aberg, Judith A2010 Jul-AugJ Clin Lipidol44
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.Smith, Kimberly ; Zheng, Lu ; Bosch, Ronald ; Margolis, David M ; Tenorio, Allan ; Napolitano, Laura ; Saag, Michael ; Connick, Elizabeth ; Gross, Barry ; Francis, Isaac ; Valdez, Hernan ; Muurahainen, Norma ; Stocker, Vicky ; Pollard, Richard2010 AprAIDS Res Hum Retroviruses426
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.Deeks, Steven G ; Gange, Stephen J ; Kitahata, Mari M ; Saag, Michael S ; Justice, Amy C ; Hogg, Robert S ; Eron, Joseph J ; Brooks, John T ; Rourke, Sean B ; Gill, M John ; Bosch, Ronald J ; Benson, Constance A ; Collier, Ann C ; Martin, Jeffrey N ; Klein, Marina B ; Jacobson, Lisa P ; Rodriguez, Benigno ; Sterling, Timothy R ; Kirk, Greg2009 Nov 15Clin Infect Dis1049
A truvada hypersensitivity reaction simulating abacavir hypersensitivity.de Perio, Marie A ; Gomez, Francisco J ; Frame, Peter T ; Fichtenbaum, Carl J2007 Oct 18AIDS1621
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.Luetkemeyer, Anne F ; Kendall, Michelle A ; Nyirenda, Mulinda ; Wu, Xingye ; Ive, Prudence ; Benson, Constance A ; Andersen, Janet W ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Kumwenda, Johnstone ; Adult AIDS Clinical Trials Group A5221 Study Team2014 Apr 1J Acquir Immune Defic Syndr465
Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells.Saharia, Kapil K ; Petrovas, Constantinos ; Ferrando-Martinez, Sara ; Leal, Manuel ; Luque, Rafael ; Ive, Prudence ; Luetkemeyer, Anne ; Havlir, Diane ; Koup, Richard A2016PLoS One711
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.Stein, James H ; Brown, Todd T ; Ribaudo, Heather J ; Chen, Yun ; Yan, Mingzhu ; Lauer-Brodell, Elizabeth ; McComsey, Grace A ; Dubé, Michael P ; Murphy, Robert L ; Hodis, Howard N ; Currier, Judith S2013 Mar 27AIDS627
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.McComsey, Grace A ; Walker, Ulrich A ; Budhathoki, Chakra B ; Su, Zhaohui ; Currier, Judith S ; Kosmiski, Lisa ; Naini, Linda G ; Charles, Stéphannie ; Medvik, Kathy ; Aberg, Judith A ; AIDS Clinical Trials Group A5229 Team2010 Oct 23AIDS1624
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection.Margolis, David M ; Mukherjee, A Lisa ; Fletcher, Courtney V ; Hogg, Evelyn ; Ogata-Arakaki, Debra ; Petersen, Tianna ; Rusin, David ; Martinez, Ana ; Mellors, John W2007 Oct 1AIDS1521
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.Grady, Benjamin J ; Torstenson, Eric S ; McLaren, Paul J ; DE Bakker, Paul I W ; Haas, David W ; Robbins, Gregory K ; Gulick, Roy M ; Haubrich, Richard ; Ribaudo, Heather ; Ritchie, Marylyn D2011Pac Symp Biocomput
Using Cognitive Interviews to Enhance Measurement in Empirical Bioethics: Developing a Measure of the Preventive Misconception in Biomedical HIV Prevention Trials.Sugarman, Jeremy ; Seils, Damon M ; Watson-Ormond, J Kemp ; Weinfurt, Kevin P2016AJOB Empir Bioeth17
Variations in self-rated health among patients with HIV infection.Mrus, Joseph M ; Schackman, Bruce R ; Wu, Albert W ; Freedberg, Kenneth A ; Tsevat, Joel ; Yi, Michael S ; Zackin, Robert2006 AprQual Life Res315
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.Yeh, Tzu-min ; Evans, Scott R ; Gulick, Roy M ; Clifford, David B2010 Jan-FebHIV Clin Trials111
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.Tsibris, Athe M N ; Hu, Zixin ; Paredes, Roger ; Leopold, Kay E ; Putcharoen, Opass ; Schure, Allison L ; Mazur, Natalie ; Coakley, Eoin ; Su, Zhaohui ; Gulick, Roy M ; Kuritzkes, Daniel R2012 JunJ Virol1286
Viral factors associated with cytokine expression during HCV/HIV co-infection.Blackard, Jason T ; Kang, Minhee ; St Clair, J Benjamin ; Lin, Wenyu ; Kamegaya, Yoshitaka ; Sherman, Kenneth E ; Koziel, Margaret James ; Peters, Marion G ; Andersen, Janet ; Chung, Raymond T ; Aids Clinical Trials Group A5071 Study Team2007 AprJ Interferon Cytokine Res427
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.Cillo, Anthony R ; Hilldorfer, Benedict B ; Lalama, Christina M ; McKinnon, John E ; Coombs, Robert W ; Tenorio, Allan R ; Fox, Lawrence ; Gandhi, Rajesh T ; Ribaudo, Heather ; Currier, Judith S ; Gulick, Roy M ; Wilkin, Timothy J ; Mellors, John W2015 Oct 23AIDS1629
The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.Markowitz, Martin ; Vaida, Florin ; Hare, C Bradley ; Boden, Daniel ; Mohri, Hiroshi ; Hecht, Frederick M ; Kalayjian, Robert C ; Conrad, Ann ; Mildvan, Donna ; Aberg, Judith ; Hogan, Christine ; Kilby, J Michael ; Balfour, Henry H ; Schafer, Kim ; Richman, Douglas ; Little, Susan2010 May 1J Infect Dis9201
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.Kang, Minhee ; Hollabaugh, Kimberly ; Pham, Vinh ; Koletar, Susan L ; Wu, Kunling ; Smurzynski, Marlene ; Aberg, Judith A2014 Jun 1J Acquir Immune Defic Syndr266
Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase.Hu, Zixin ; Hatano, Hiroyu ; Hammond, Sarah P ; Smith, Danielle ; Wild, Mary ; Gupta, Soumi ; Whitcomb, Jeannette ; Kalayjian, Robert C ; Gripshover, Barbara ; Kuritzkes, Daniel R2007 Aug 15J Acquir Immune Defic Syndr545
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.Mitsuyasu, Ronald ; Gelman, Rebecca ; Cherng, Deborah Weng ; Landay, Alan ; Fahey, John ; Reichman, Richard ; Erice, Alejo ; Bucy, R Pat ; Kilby, J Michael ; Lederman, Michael M ; Hamilton, Carol D ; Lertora, Juan ; White, Becky L ; Tebas, Pablo ; Duliege, Anne-Marie ; Pollard, Richard B ; AIDS Clinical Trials Group 328 Study Team2007 Mar 26Arch Intern Med6167
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Overton, Edgar Turner ; Chan, Ellen S ; Brown, Todd T ; Tebas, Pablo ; McComsey, Grace A ; Melbourne, Kathleen M ; Napoli, Andrew ; Hardin, William Royce ; Ribaudo, Heather J ; Yin, Michael T2015 Jun 16Ann Intern Med12162
Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.Natsag, J ; Kendall, M A ; Sellmeyer, D E ; McComsey, G A ; Brown, T T2016 MarHIV Med317
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.Erlandson, Kristine M ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Tebas, Pablo ; Melbourne, Kathleen ; Ha, Belinda ; Jahed, Nasreen C ; McComsey, Grace A2013 Aug 24AIDS1327
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.Gilbert, Peter B ; DeGruttola, Victor G ; Hudgens, Michael G ; Self, Steven G ; Hammer, Scott M ; Corey, Lawrence2003 Jul 15J Infect Dis2188
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.Brehm, Jessica H ; Scott, Yanille ; Koontz, Dianna L ; Perry, Steven ; Hammer, Scott ; Katzenstein, David ; Mellors, John W ; Sluis-Cremer, Nicolas ; AIDS Clinical Trials Group Study 175 Protocol Team2012PLoS One27